Amedeo Smart

Free Medical Literature Service

 

Amedeo

Obstructive Lung Diseases
  Free Subscription

Articles published in
Respir Med
    December 2024
  1. DONOHUE P, Connolly M, D'Alfonso M, Jackson G, et al
    Peripheral Airways Dysfunction Measured by Oscillometry Differentiates Asthma from Inducible Laryngeal Obstruction.
    Respir Med. 2024 Dec 2:107905. doi: 10.1016/j.rmed.2024.107905.
    >> Share

    November 2024
  2. GEMICIOGLU B, Gokmen D, Can A, Sevinc C, et al
    Factors Influencing the Prescription of Add-on Long-Acting Muscarinic Antagonists in Real-World Asthma Management: Insights from a National Registry.
    Respir Med. 2024 Nov 29:107883. doi: 10.1016/j.rmed.2024.107883.
    >> Share

  3. FARSHID S, Buckland BC, Shanmuganathan S, Low GK, et al
    End-tidal carbon dioxide, a point-of-care biomarker to assess severity in acute asthma: A systematic review.
    Respir Med. 2024 Nov 29:107891. doi: 10.1016/j.rmed.2024.107891.
    >> Share

  4. YASUI H, Oishi K, Nihashi F, Furuhashi K, et al
    Factors associated with uncontrolled severe asthma in the biologic era.
    Respir Med. 2024;236:107881.
    >> Share

  5. ERRASTI VIADER J, Martinez Gonzalez MA, Campo Ezquibela A, Bes-Rastrollo M, et al
    Dietary patterns and asthma incidence in adult population. Systematic review and meta-analysis.
    Respir Med. 2024 Nov 19:107861. doi: 10.1016/j.rmed.2024.107861.
    >> Share

  6. GANGEMI AJ, Dass CA, Zhao H, Patel M, et al
    Advanced Emphysema Leads to High False Positivity Rate for Pneumothorax in Point of Care Ultrasound.
    Respir Med. 2024 Nov 16:107860. doi: 10.1016/j.rmed.2024.107860.
    >> Share

  7. SESHADRI N, Faig W, Young LR, Hill DA, et al
    Risk Factors for Hospitalization in Subspecialty Patients with Severe Persistent Asthma.
    Respir Med. 2024 Nov 15:107867. doi: 10.1016/j.rmed.2024.107867.
    >> Share

  8. GOMEZ LF, Kinnee E, Kaufman JD, Young MT, et al
    Modification of asthma treatment efficacy by healthcare access: A reanalysis of AsthmaNet Step-Up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations (STICS) clinical trial.
    Respir Med. 2024;234:107853.
    >> Share

  9. HUG S, Cavalheri V, Hill K, Gucciardi DF, et al
    Road to referral success in COPD: Enhancing patient engagement through dedicated conversations about pulmonary rehabilitation programs.
    Respir Med. 2024;233:107790.
    >> Share

  10. LI C, Lian X, He J, Gao X, et al
    Association of computed tomography-derived pectoralis muscle area and density with disease severity and respiratory symptoms in patients with chronic obstructive pulmonary disease: A case-control study.
    Respir Med. 2024;233:107783.
    >> Share

  11. GRASL MT, Agusti A, Azizzadeh M, Karimi A, et al
    Prevalence and etiotypes of persistent airflow obstruction in the general population across the lifetime.
    Respir Med. 2024;233:107779.
    >> Share

  12. HAMADA R, Tanabe N, Oshima Y, Yoshioka Y, et al
    Phase angle measured by bioelectrical impedance analysis in patients with chronic obstructive pulmonary disease: Associations with physical inactivity and frailty.
    Respir Med. 2024;233:107778.
    >> Share

  13. HANSEN KK, Hilberg O, Lokke A
    High prevalence of undiagnosed and treatment-requiring obstructive sleep apnea and nocturnal desaturation in outpatients with severe chronic obstructive pulmonary disease.
    Respir Med. 2024;233:107771.
    >> Share

  14. ALQAHTANI JS, Arowosegbe A, Aldhahir AM, Alghamdi SM, et al
    Prevalence and burden of loneliness in COPD: A systematic review and meta-analysis.
    Respir Med. 2024;233:107768.
    >> Share

  15. IGNACIO CARLOTTO C, Bernardes S, Zanella P, Silva FM, et al
    Dietary patterns and risk of Chronic Obstructive Pulmonary Disease (COPD) and clinical outcomes in diagnosed patients: A scoping review.
    Respir Med. 2024;233:107773.
    >> Share

  16. BAKKER JT, Hartman JE, Klooster K, Charbonnier JP, et al
    Endobronchial valve treatment improves chest-CT diaphragm configuration in COPD.
    Respir Med. 2024;234:107856.
    >> Share

  17. BOERSMA R, Bakker JT, de Vries M, Raveling T, et al
    Defining a phenotype of severe COPD patients who develop chronic hypercapnia.
    Respir Med. 2024;234:107850.
    >> Share

  18. BUCHARDT STE, Weinreich UM, Lindgren FL, Lauridsen MD, et al
    Patient characteristics and mortality across diagnostic settings in COPD.
    Respir Med. 2024;234:107843.
    >> Share

  19. SAADI R, Rangwala R, Shaikh H, Laghi F, et al
    The effects of noninvasive respiratory support on swallowing physiology, airway protection, and respiratory-swallow pattern in adults: A systematic review.
    Respir Med. 2024;234:107844.
    >> Share

  20. PHANTAYUTH D, Chuaychoo B, Supaporn S, Nana A, et al
    Effectiveness of a 12-week combining tai chi and yoga program on pulmonary function and functional fitness in COPD patients.
    Respir Med. 2024;234:107842.
    >> Share

  21. HOU XF, Hou CG
    Association between acute tobacco exposure and fractional exhaled nitric oxide in patients with chronic obstructive pulmonary disease: National health and Nutrition Examination Survey (NHANES) 2007-2012.
    Respir Med. 2024;234:107831.
    >> Share

  22. CHOATE R, Holm KE, Sandhaus RA, Mannino DM, et al
    Physical and mental health trajectories: A longitudinal SF-36 analysis in Alpha-1 antitrypsin deficiency-associated COPD.
    Respir Med. 2024;234:107838.
    >> Share

  23. TOFOLI TM, Santin L, Medeiros L, Silva H, et al
    Determinant factors of sedentary time in individuals with COPD.
    Respir Med. 2024;234:107839.
    >> Share

  24. TAN DJ, Finlay P, Siu H, Fan IM, et al
    Impaired diffusing capacity and COPD incidence in adults with symptoms and normal spirometry.
    Respir Med. 2024;234:107832.
    >> Share

  25. COX NS, Barton C, Bondarenko J, Clark R, et al
    Characterizing pulmonary rehabilitation referrals from primary care.
    Respir Med. 2024;234:107822.
    >> Share

  26. SHANMUGAVEL GEETHA H, Teo YX, Ravichandran S, Perkit NR, et al
    Use of Sodium-glucose cotransporter 2 (SGLT 2) inhibitor is associated with reduced emergency room visits and hospitalizations in patients with Chronic obstructive pulmonary disease (COPD) and type 2 Diabetes Mellitus.
    Respir Med. 2024;234:107819.
    >> Share

  27. ZHU Z
    Advancements in automated classification of chronic obstructive pulmonary disease based on computed tomography imaging features through deep learning approaches.
    Respir Med. 2024;234:107809.
    >> Share

  28. SHI Q, Xu J, Zeng L, Lu Z, et al
    A nomogram for predicting short-term mortality in ICU patients with coexisting chronic obstructive pulmonary disease and congestive heart failure.
    Respir Med. 2024;234:107803.
    >> Share

  29. JANG JG, Kim Y, Shin SH, Min KH, et al
    The role of FEV(1)/FVC in the prediction of acute exacerbation of COPD.
    Respir Med. 2024;234:107780.
    >> Share

    October 2024
  30. BHATT SP, Rabe KF, Hanania NA, Vogelmeier CF, et al
    Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS).
    Respir Med. 2024 Oct 29:107846. doi: 10.1016/j.rmed.2024.107846.
    >> Share

  31. CAZZOLA M, Ora J, Calzetta L, Rogliani P, et al
    beta-Blockers and Asthma: Surprising Findings from the FAERS Database.
    Respir Med. 2024 Oct 26:107849. doi: 10.1016/j.rmed.2024.107849.
    >> Share

  32. BOURBEAU J
    In COPD- right treatment, right patient, right time, right approach?
    Respir Med. 2024;232:107769.
    >> Share

  33. PANTAZOPOULOS I, Boutlas S, Mavrovounis G, Papalampidou A, et al
    Nasal high flow or noninvasive ventilation? navigating hypercapnic COPD exacerbation treatment: A randomized noninferiority clinical trial.
    Respir Med. 2024;232:107762.
    >> Share

  34. LAURIDSEN MD, Grontved S, Fosbol E, Johnsen SP, et al
    Treatment intensity level as a proxy for severity of chronic obstructive pulmonary disease: A risk stratification tool.
    Respir Med. 2024;232:107742.
    >> Share

  35. ZHENG K, Tang L, Wang X, Chen L, et al
    The risk factors for chronic cough in children: A meta-analysis covering five continents.
    Respir Med. 2024;232:107752.
    >> Share

  36. WU W, Guan L, Guo B, Yang Y, et al
    Respiratory physiological mechanism of two types of equal-intensity inspiratory muscle training in stable patients with chronic obstructive pulmonary disease.
    Respir Med. 2024;232:107747.
    >> Share

  37. WU WW
    Association of naples prognostic score and lung health: A population-based study.
    Respir Med. 2024;232:107751.
    >> Share

  38. DELACOSTE FBC, Goulart CDL, Guidoti AB, Turck P, et al
    Evaluating the impact of short-term nitrate-rich dietary supplementation on endothelial function in COPD: A randomized crossover study.
    Respir Med. 2024;232:107745.
    >> Share

  39. MUNOZ MONTIEL A, Ruiz-Esteban P, Domenech Del Rio A, Valdivielso P, et al
    The effect of pulmonary rehabilitation on cardiovascular risk, oxidative stress and systemic inflammation in patients with COPD.
    Respir Med. 2024;232:107740.
    >> Share

    September 2024
  40. HAMELMANN E, Csonka P, Roberts G, Vogelberg C, et al
    High burden of respiratory allergy in children warrants early identification and treatment with allergen immunotherapy.
    Respir Med. 2024 Sep 24:107812. doi: 10.1016/j.rmed.2024.107812.
    >> Share

  41. HAKANSSON KEJ, Alabdulkarim N, Guerrero SC, Backer V, et al
    Real-world phenotyping and risk assessment of childhood asthma burden using national registries.
    Respir Med. 2024;234:107808.
    >> Share

  42. NOPSOPON T, Brown A, Hahn G, Rank M, et al
    Temporal variation in the effectiveness of biologics in asthma: Effect modification by changing patient characteristics.
    Respir Med. 2024 Sep 9:107802. doi: 10.1016/j.rmed.2024.107802.
    >> Share

  43. FAT M, Andersen T, Fazio JC, Park SC, et al
    Association of bronchial disease on CT imaging and clinical definitions of chronic bronchitis in a single-center COPD phenotyping study.
    Respir Med. 2024;231:107733.
    >> Share

  44. BISHOP JA, Spencer LM, Dwyer TJ, McKeough ZJ, et al
    Patterns of physical activity of people with COPD during participation in a pulmonary rehabilitation program.
    Respir Med. 2024;231:107724.
    >> Share

  45. SCHAFAUSER NS, Sampaio LMM, Heubel AD, Kabbach EZ, et al
    Influence of heart failure (HF) comorbidity in chronic obstructive pulmonary disease (COPD) and isolated forms of HF and COPD on cardiovascular function during hospitalization.
    Respir Med. 2024;231:107731.
    >> Share

  46. WSHAH A, Alqatarneh N, Al-Nassan S, Goldstein R, et al
    Factors related to the implementation of pulmonary rehabilitation in Jordan: Perspective of healthcare professionals.
    Respir Med. 2024;231:107728.
    >> Share

  47. GUO L, Bilimoria SN, Kikuchi R, Hao A, et al
    Prevalence, incidence, and risk of chronic obstructive pulmonary disease among psoriasis patients.
    Respir Med. 2024;231:107729.
    >> Share

  48. SMIRNOVA N, Cross SH, Light A, Kavalieratos D, et al
    Racial differences in palliative care and hospice among adults with chronic obstructive pulmonary disease.
    Respir Med. 2024;231:107719.
    >> Share

  49. QUEZADA WA, Angulo D, Murray S, Joo M, et al
    Exacerbation-like events in the 12 months prior to identification of chronic respiratory conditions in a primary care population.
    Respir Med. 2024;231:107695.
    >> Share

  50. RISEBROUGH NA, Mursleen S, Ndirangu K, Shah D, et al
    The long-term clinical and economic benefits of treating advanced COPD patients with single-inhaler triple therapy in Quebec, Canada - The IMPACT trial.
    Respir Med. 2024;231:107694.
    >> Share

    August 2024
  51. WHARTON R, Mathis N, Wang JG, Meislin R, et al
    Feasibility of Remote Spirometry Monitoring of Asthma in Pregnancy.
    Respir Med. 2024 Aug 24:107782. doi: 10.1016/j.rmed.2024.107782.
    >> Share

  52. WEBB EM, Holland AE, Chang AB, Burr L, et al
    Current physiotherapy practice for adults with bronchiectasis: Data from the Australian bronchiectasis registry.
    Respir Med. 2024;233:107777.
    >> Share

  53. TERL M, Diamant Z, Kosturiak R, Jesenak M, et al
    Choosing the right biologic treatment for individual patients with severe asthma - lessons learnt from Picasso.
    Respir Med. 2024 Aug 22:107766. doi: 10.1016/j.rmed.2024.107766.
    >> Share

  54. NORWEG A, Oh C, Nolan A
    Onion Consumption is Protective Against Asthma Risk in Children: ROAD to Health Population-based Cohort Study.
    Respir Med. 2024 Aug 11:107767. doi: 10.1016/j.rmed.2024.107767.
    >> Share

  55. DITTRICH AS, Kontogianni K, Unterschemmann AS, De Rossi S, et al
    Efficacy and safety of simultaneous combined Zephyr and Spiration valve therapy in patients with advanced pulmonary emphysema.
    Respir Med. 2024 Aug 2:107760. doi: 10.1016/j.rmed.2024.107760.
    >> Share

  56. KIZMAZ E, Telli Atalay O, Cetin N, Ugurlu E, et al
    Virtual reality for COPD exacerbation: A randomized controlled trial.
    Respir Med. 2024;230:107696.
    >> Share

  57. KARJALAINEN J, Vartiainen V, Tikkakoski A, Malmberg LP, et al
    Salbutamol Easyhaler provides non-inferior relief of methacholine induced bronchoconstriction in comparison to Ventoline Evohaler with spacer: A randomized trial.
    Respir Med. 2024;230:107693.
    >> Share

  58. NGUYEN KT, Brooks D, Macedo LG, Ellerton C, et al
    Balance measures for fall risk screening in community-dwelling older adults with COPD: A longitudinal analysis.
    Respir Med. 2024;230:107681.
    >> Share

  59. JOO H, Yoon HK, Hwang YI, Kim SH, et al
    Application of the Lancet Commission COPD classification to COPD Cohort Population in South Korea.
    Respir Med. 2024;230:107679.
    >> Share

    July 2024
  60. BULT L, Thelen JC, Rauh SP, Veen JCCMI', et al
    Dupilumab responder types and predicting factors in patients with type 2 severe asthma: a real-world cohort study.
    Respir Med. 2024 Jul 9:107720. doi: 10.1016/j.rmed.2024.107720.
    >> Share

  61. LOCCI C, Puci MV, Saderi L, Sotgiu G, et al
    The complex link between sleep-disordered breathing and asthma control in pediatric patients: a cross-sectional study.
    Respir Med. 2024 Jul 2:107730. doi: 10.1016/j.rmed.2024.107730.
    >> Share

  62. SORIANO JB, Polverino F
    Sexual activity and respiratory disease: A systematic review.
    Respir Med. 2024;228:107665.
    >> Share

  63. LIAO KM, Chiu CC, Lu HY
    The risk of secondary spontaneous pneumothorax in patients with chronic obstructive pulmonary disease in Taiwan.
    Respir Med. 2024;228:107672.
    >> Share

  64. LI L, Wang L, Zhang L, Zhao C, et al
    Frailty and in-hospital mortality in older patients with acute exacerbation of COPD: A real-world prospective cohort study.
    Respir Med. 2024;228:107663.
    >> Share

  65. YOUNES A, Mandigout S, Robin L, Borel B, et al
    What kind of non-pharmacological strategy for reducing sedentary behavior in COPD? Data from a scoping review.
    Respir Med. 2024;228:107662.
    >> Share

    June 2024
  66. VISSER CD, Faay MRA, Ozdemir A, Guchelaar HJ, et al
    Short-acting beta(2)-agonists (SABA) overuse in asthma and patients' perceptions for this behavior.
    Respir Med. 2024 Jun 25:107723. doi: 10.1016/j.rmed.2024.107723.
    >> Share

  67. PACKHAM S, Odling M, Bossios A, Konradsen JR, et al
    Adherence to inhaled corticosteroid therapy and treatment escalation in the Swedish adult asthma population.
    Respir Med. 2024;231:107714.
    >> Share

  68. HE ZF, Lin SZ, Pan CX, Chen ZM, et al
    The roles of bacteria and viruses in COPD-Bronchiectasis association: A prospective cohort study.
    Respir Med. 2024 Jun 7:107692. doi: 10.1016/j.rmed.2024.107692.
    >> Share

  69. MARTINEZ-GONZALEZ CL, Camargo Fajardo MCC, Martinez-Ortiz EJ, Segura Medina P, et al
    A soft systems approach of asthma management in children based on therapeutic education and e-learning.
    Respir Med. 2024 Jun 4:107691. doi: 10.1016/j.rmed.2024.107691.
    >> Share

  70. ISLAM N, Reid D
    Inhaled antibiotics: A promising drug delivery strategies for efficient treatment of lower respiratory tract infections (LRTIs) associated with antibiotic resistant biofilm-dwelling and intracellular bacterial pathogens.
    Respir Med. 2024;227:107661.
    >> Share

  71. RAZJOUYAN J, Hanania NA, Nowakowski S, Agrawal R, et al
    Identification of sleep phenotypes in COPD using machine learning-based cluster analysis.
    Respir Med. 2024;227:107641.
    >> Share

  72. CHOUDHURY P, Dasgupta S, Kar A, Sarkar S, et al
    Bioinformatics analysis of hypoxia associated genes and inflammatory cytokine profiling in COPD-PH.
    Respir Med. 2024;227:107658.
    >> Share

  73. KOSTER TD, Shah PL, Valipour A, Criner GJ, et al
    Optimizing clinical outcomes for bronchoscopic lung volume reduction with Zephyr(R) valves.
    Respir Med. 2024;227:107639.
    >> Share

  74. GOMES VMR, Pires MC, Delfino Pereira P, Schwarzbold AV, et al
    AB(2)CO risk score for in-hospital mortality of COVID-19 patients admitted to intensive care units.
    Respir Med. 2024;227:107635.
    >> Share

  75. ZELL-BARAN LM, Krefft SD, Strand M, Rose CS, et al
    Longitudinal changes in lung function following post-9/11 military deployment in symptomatic veterans.
    Respir Med. 2024;227:107638.
    >> Share

  76. YOHANNES AM, Casaburi R, Dryden S, Hanania NA, et al
    Sex differences and determinants of anxiety symptoms in patients with COPD initiating pulmonary rehabilitation.
    Respir Med. 2024;227:107633.
    >> Share

  77. LAPI F, Marconi E, Lombardo FP, Cricelli I, et al
    Development and validation of a prediction score to assess the risk of incurring in COPD-related exacerbations: a population-based study in primary care.
    Respir Med. 2024;227:107634.
    >> Share

    May 2024
  78. LO CASTO M, Marino S, Zammuto MM, Tomasello A, et al
    Patients with bronchiectasis have a lower combined risk of cardiovascular risk factors and cardiovascular comorbidity compared to patients with COPD.
    Respir Med. 2024;229:107683.
    >> Share

  79. AL-AHMAD M, Al Zaabi A, Madkour A, Alqaraghuli HA, et al
    Expert Consensus on Oral Corticosteroids Stewardship for the Treatment of Severe Asthma in the Middle East and Africa.
    Respir Med. 2024 May 21:107674. doi: 10.1016/j.rmed.2024.107674.
    >> Share

  80. AKSAMIT TR, Lapinel NC, Choate R, Feliciano J, et al
    Association between bronchiectasis exacerbations and longitudinal changes in FEV(1) in patients from the US Bronchiectasis and NTM Research Registry.
    Respir Med. 2024 May 9:107660. doi: 10.1016/j.rmed.2024.107660.
    >> Share

  81. ZHOU Y, Duan S, Zhang L, Peng F, et al
    Cost-effectiveness analysis of fluticasone furoate/umeclidinium bromide/vilanterol and umeclidinium bromide/vilanterol in the management of moderate and severe COPD in China.
    Respir Med. 2024;226:107632.
    >> Share

  82. BETANCOR D, Barroso B, Valverde-Monge M, Gomez-Lopez A, et al
    The discrepancy in bronchodilator response between ATS/ERS 2021 and 1991 criteria.
    Respir Med. 2024;226:107609.
    >> Share

  83. STOUSTRUP AL, Janssen DJA, Nakken N, Wouters EFM, et al
    Association of inadequate social support and clinical outcomes in patients with chronic obstructive pulmonary disease - A cross-sectional study.
    Respir Med. 2024;226:107625.
    >> Share

  84. LUNDELL S, Isaksson U, Coe AB, Harrison SL, et al
    Swedish translation and psychometric testing of the Self-Conscious Emotions in COPD Questionnaire.
    Respir Med. 2024;226:107624.
    >> Share

  85. LUU B, Chinnadurai A, Choudhary O, Breede N, et al
    A comprehensive evaluation of online inhaler use techniques for obstructive airway disease.
    Respir Med. 2024;226:107607.
    >> Share

  86. ZYSMAN M, Coquelin A, Le Guen N, Solomiac A, et al
    Prevalence and disparities in influenza vaccination among patients with COPD: A French nationwide population study.
    Respir Med. 2024;226:107606.
    >> Share

    April 2024
  87. GOTO T, Hernandez CG, Tsujimoto Y, Kitagawa T, et al
    Are biologics effective on lung hyperinflation in patients with resistant asthma?
    Respir Med. 2024 Apr 30:107652. doi: 10.1016/j.rmed.2024.107652.
    >> Share

  88. CAZZOLA M, Maniscalco M
    Are biologics effective on lung hyperinflation in patients with resistant asthma? A reply.
    Respir Med. 2024 Apr 26:107653. doi: 10.1016/j.rmed.2024.107653.
    >> Share

  89. JI H, Tan LD, Hafzella G, Nguyen N, et al
    Navigating Biologic Therapies in Elderly Asthma.
    Respir Med. 2024 Apr 26:107655. doi: 10.1016/j.rmed.2024.107655.
    >> Share

  90. CANONICA GW, Domingo C, Lavoie KL, Kaliasethi A, et al
    Asthma patients' and physicians' perspectives on the burden and management of asthma: post-hoc analysis of APPaRENT 1 and 2 to assess predictors of treatment adherence.
    Respir Med. 2024 Apr 16:107637. doi: 10.1016/j.rmed.2024.107637.
    >> Share

  91. ROBERTS MH, Duh MS, Rothnie KJ, Zhang S, et al
    Development and validation of a claims-based algorithm to identify moderate exacerbations in patients with asthma treated in the US.
    Respir Med. 2024 Apr 7:107630. doi: 10.1016/j.rmed.2024.107630.
    >> Share

  92. SHENG DUH M, Roberts MH, Rothnie KJ, Cheng WY, et al
    Frequency and economic burden of exacerbations in inhaled corticosteroid/long-acting beta-agonist-treated patients with asthma: a retrospective US claims study.
    Respir Med. 2024 Apr 7:107629. doi: 10.1016/j.rmed.2024.107629.
    >> Share

  93. FARKAS A, Horvath A, Reti I, Ilyes N, et al
    Comparative study of the inhalation parameters of COPD patients through NEXThaler(R) and Ellipta(R) dry powder inhalers.
    Respir Med. 2024;224:107576.
    >> Share

  94. MONDAL P, Lopez SP, Khokhar A, Snyder D, et al
    The influence of body mass index on airway resistance in children with sickle cell disease: A longitudinal study based on impulse oscillometry.
    Respir Med. 2024;224:107564.
    >> Share

  95. MAROTT JL, Ingebrigtsen TS, Colak Y, Vestbo J, et al
    Predicting exacerbations in COPD in the Danish general population.
    Respir Med. 2024;224:107557.
    >> Share

  96. BROCKWAY K, Ahmed S
    Beyond breathing: Systematic review of global chronic obstructive pulmonary disease guidelines for pain management.
    Respir Med. 2024;224:107553.
    >> Share

  97. LAI K, Sun D, Dai R, Samoro R, et al
    Benralizumab efficacy and safety in severe asthma: A randomized trial in Asia.
    Respir Med. 2024 Apr 1:107611. doi: 10.1016/j.rmed.2024.107611.
    >> Share

  98. GOTO T, Banno M, Kimura R
    Revisiting the use of high flow nasal cannula in acute exacerbation of COPD and conclusion of trial.
    Respir Med. 2024;225:107602.
    >> Share

  99. LORENZANA I, Galera R, Casitas R, Martinez-Ceron E, et al
    Dynamic hyperinflation is a risk factor for mortality and severe exacerbations in COPD patients.
    Respir Med. 2024;225:107597.
    >> Share

  100. XU X, Yin J, Yang Y, Liu H, et al
    Advances in co-pathogenesis of the united airway diseases.
    Respir Med. 2024;225:107580.
    >> Share

  101. STEGER M, Canuet M, Enache I, Goetsch T, et al
    Survival and response to pulmonary vasodilator therapies in patients with chronic obstructive pulmonary disease and pulmonary vascular phenotype.
    Respir Med. 2024;225:107585.
    >> Share

  102. BELL K, Lawson J, Penz E, Cammer A, et al
    Systematic review of tailored dietary advice and dietitian involvement in the treatment of chronic obstructive pulmonary disease (COPD).
    Respir Med. 2024;225:107584.
    >> Share

  103. VERWEEL L, Packham T, Goldstein R, Brooks D, et al
    Implementation of virtual pulmonary rehabilitation during the COVID-19 pandemic: Experiences and perceptions of patients and healthcare providers.
    Respir Med. 2024;225:107588.
    >> Share

  104. LUO L, Tang J, Du X, Li N, et al
    Chronic obstructive pulmonary disease and the airway microbiome: A review for clinicians.
    Respir Med. 2024;225:107586.
    >> Share

    March 2024
  105. YORGANCIOGLU A, Cruz AA, Garcia G, Lavoie KL, et al
    A network meta-analysis of the association between patient traits and response to regular dosing with ICS plus short-acting beta(2)-agonist reliever or ICS/formoterol reliever only in mild asthma.
    Respir Med. 2024 Mar 30:107610. doi: 10.1016/j.rmed.2024.107610.
    >> Share

  106. JEONG J, Nam YH, Sim DW, Kim BK, et al
    Relationship of computed tomography-based measurements with symptom perception and quality of life in patients with severe asthma.
    Respir Med. 2024;225:107598.
    >> Share

  107. WIJSMAN PC, Goorsenberg AWM, d'Hooghe JNS, Weersink EJM, et al
    Exhaled breath analyses for bronchial thermoplasty in severe asthma patients.
    Respir Med. 2024 Mar 4:107583. doi: 10.1016/j.rmed.2024.107583.
    >> Share

  108. NIERI D, Morani C, De Francesco M, Gaeta R, et al
    Enhanced prothrombotic and proinflammatory activity of circulating extracellular vesicles in acute exacerbations of chronic obstructive pulmonary disease.
    Respir Med. 2024;223:107563.
    >> Share

  109. LAI Y, Cavalheri V, Sawyer A, Hill K, et al
    Exercise training initiated early during hospitalisation in individuals with chronic obstructive pulmonary disease is safe and improves exercise capacity and physical function at hospital discharge: A systematic review and meta-analysis.
    Respir Med. 2024;223:107554.
    >> Share

  110. LAU F, Schupp T, Schmitt A, Reinhardt M, et al
    Prognostic impact of chronic obstructive pulmonary disease in patients with heart failure with mildly reduced ejection fraction.
    Respir Med. 2024;223:107536.
    >> Share

    February 2024
  111. MANISCALCO M, Candia C, Calabrese C, D'Amato M, et al
    Impact of biologics on lung hyperinflation in patients with severe asthma.
    Respir Med. 2024 Feb 29:107578. doi: 10.1016/j.rmed.2024.107578.
    >> Share

  112. ALMQVIST L, Andersson M, Backman H, Ronmark E, et al
    No remission in 60% of those with childhood-onset asthma - A population-based cohort followed from 8 to 28 years of age.
    Respir Med. 2024 Feb 26:107581. doi: 10.1016/j.rmed.2024.107581.
    >> Share

  113. POSTHUMA R, van der Molen MC, Hartman JE, Spruit MA, et al
    Treatable traits in advanced emphysema patients eligible for bronchoscopic lung volume reduction with endobronchial valves.
    Respir Med. 2024 Feb 17:107558. doi: 10.1016/j.rmed.2024.107558.
    >> Share

  114. HOGARTH DK, Delage A, Zgoda MA, Nsiah-Dosu S, et al
    Efficacy and safety of the spiration valve System for the treatment of severe emphysema in patients with Alpha-1 antitrypsin deficiency (EMPROVE).
    Respir Med. 2024;224:107565.
    >> Share

  115. ROTT C, Limen E, Kriegsmann K, Herth F, et al
    Analysis of body composition with bioelectrical impedance analysis in patients with severe COPD and pulmonary emphysema.
    Respir Med. 2024 Feb 11:107559. doi: 10.1016/j.rmed.2024.107559.
    >> Share

  116. FARZANDIPOUR M, Arani MH, Sharif R, Nabovati E, et al
    Improving asthma control and quality of life via a smartphone self-management app: A randomized controlled trial.
    Respir Med. 2024 Feb 5:107539. doi: 10.1016/j.rmed.2024.107539.
    >> Share

  117. WU F, Dai C, Zhou Y, Deng Z, et al
    Tiotropium reduces clinically important deterioration in patients with mild-to-moderate chronic obstructive pulmonary disease: A post hoc analysis of the Tie-COPD study.
    Respir Med. 2024;222:107527.
    >> Share

  118. KO FWS, Xu X, Chau C, Navarro A, et al
    Clinical characteristics and healthcare resource utilization in patients with chronic obstructive pulmonary disease in Hong Kong.
    Respir Med. 2024;222:107516.
    >> Share

  119. JAMES BD, Greening NJ, Tracey N, Haldar P, et al
    Prognostication of co-morbidity clusters on hospitalisation and mortality in advanced COPD.
    Respir Med. 2024;222:107525.
    >> Share

  120. OVENHOLM H, Zaigham S, Frantz S, Nihlen U, et al
    Inhomogeneity of ventilation in smokers and mild COPD assessed by the ratio of alveolar volume to total lung capacity.
    Respir Med. 2024;222:107524.
    >> Share

  121. ALVAREZ-DOBANO JM, Rodriguez-Garcia C, Atienza G, Toubes ME, et al
    Analysis of the quality of e-Consultations in chronic obstructive pulmonary disease.
    Respir Med. 2024;222:107514.
    >> Share

  122. ZHANG Y, Peng J, Liu L, Cui H, et al
    Prevalence, characteristics and significant predictors for cardiovascular disease of patients with preserved ratio impaired spirometry: A 10-year prospective cohort study in China.
    Respir Med. 2024;222:107523.
    >> Share

  123. WANG J, Feng F, Zhao Y, Bai L, et al
    Dietary nitrate supplementation to enhance exercise capacity in patients with COPD: Evidence from a meta-analysis of randomized controlled trials and a network pharmacological analysis.
    Respir Med. 2024;222:107498.
    >> Share

  124. VOGELMEIER CF, Friedrich FW, Timpel P, Kossack N, et al
    Impact of COPD on mortality: An 8-year observational retrospective healthcare claims database cohort study.
    Respir Med. 2024;222:107506.
    >> Share

  125. COMETA M, Ursitti A, Lombardo LP, Rana R, et al
    Can the Rome classification of chronic obstructive pulmonary disease exacerbation severity be applied in the hospital setting?
    Respir Med. 2024;222:107509.
    >> Share

  126. QAISAR R, Karim A, Muhammad T, Ahmad F, et al
    Butyrate supplementation reduces sarcopenia by repairing neuromuscular junction in patients with chronic obstructive pulmonary disease.
    Respir Med. 2024;222:107510.
    >> Share

  127. LIU H, Xie Y, Huang Y, Luo K, et al
    The association between blood eosinophils and clinical outcome of acute exacerbations of chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Respir Med. 2024;222:107501.
    >> Share

    January 2024
  128. BASAVARAJ A, Choate R, Becker BC, Aksamit TR, et al
    Severity of bronchiectasis predicts use of and adherence to high frequency chest wall oscillation therapy - Analysis from the United States Bronchiectasis and NTM research registry.
    Respir Med. 2024 Jan 31:107555. doi: 10.1016/j.rmed.2024.107555.
    >> Share

  129. ZHANG T, Xu L, Zhang Y, Zhen L, et al
    The diagnostic value of bronchial provocation testing combined with fractional exhaled nitric oxide (FeNO) in children with chest tightness-variant asthma (CTVA).
    Respir Med. 2024 Jan 27:107543. doi: 10.1016/j.rmed.2024.107543.
    >> Share

  130. PAPI A, Castro M, Corren J, Pavord ID, et al
    Dupilumab sustains lung function improvements in patients with moderate-to-severe asthma.
    Respir Med. 2024 Jan 23:107535. doi: 10.1016/j.rmed.2024.107535.
    >> Share

  131. CHASE NM, Littlejohn M, Holweg CTJ, Millette LA, et al
    Effectiveness of omalizumab across different dosing regimens in patients with moderate-to-severe allergic asthma.
    Respir Med. 2024 Jan 20:107537. doi: 10.1016/j.rmed.2024.107537.
    >> Share

  132. SIORA A, Vontetsianos A, Chynkiamis N, Anagnostopoulou C, et al
    Small airways in asthma: From inflammation and pathophysiology to treatment response.
    Respir Med. 2024 Jan 14:107532. doi: 10.1016/j.rmed.2024.107532.
    >> Share

  133. BACKMAN H, Lindmark SW, Hedman L, Kankaanranta H, et al
    The interplay between obesity and blood neutrophils in adult-onset asthma.
    Respir Med. 2024 Jan 10:107529. doi: 10.1016/j.rmed.2024.107529.
    >> Share

  134. BRESLAVSKY A, Al Qaied A, Tsenter P, Mukaseev N, et al
    Comparison of clinical remission criteria for severe asthma patients receiving biologic therapy.
    Respir Med. 2024 Jan 8:107528. doi: 10.1016/j.rmed.2024.107528.
    >> Share

  135. NORWEG A, Hofferber B, Maguire S, Oh C, et al
    Breathing on the mind: Treating dyspnea and anxiety symptoms with biofeedback in chronic lung disease - A qualitative analysis.
    Respir Med. 2024;221:107505.
    >> Share

  136. MIRAVITLLES M, Criner GJ, Mall MA, Rowe SM, et al
    Potential systemic effects of acquired CFTR dysfunction in COPD.
    Respir Med. 2024;221:107499.
    >> Share

  137. DELMAS MC, Pasquereau A, Renuy A, Benezet L, et al
    Electronic cigarette use and respiratory symptoms in the French population-based Constances cohort.
    Respir Med. 2024;221:107496.
    >> Share

  138. HUANG X, Gu H, Wu R, Chen L, et al
    Chest imaging classification in Mycoplasma pneumoniae pneumonia is associated with its clinical features and outcomes.
    Respir Med. 2024;221:107480.
    >> Share

  139. SANTOS EAD, Pinto TF, Xavier RF, Stelmach R, et al
    Elastic tape reduces dyspnea and improves health status in the short term in nonobese COPD males: A randomized controlled trial.
    Respir Med. 2024;221:107459.
    >> Share

    December 2023
  140. VISSER E, Ten Brinke A, Sizoo D, Pepels JJS, et al
    Effect of dietary interventions on markers of type 2 inflammation in asthma: A systematic review.
    Respir Med. 2023;221:107504.
    >> Share

  141. DE-MIGUEL-DIEZ J, Gutierrez-Albaladejo N, Caballero-Segura FJ, Lopez-de-Andres A, et al
    Trends and sex differences in atrial fibrillation among patients hospitalized due to asthma: Insights from a nationwide population-based discharge database in Spain, 2016-2021.
    Respir Med. 2023;221:107508.
    >> Share

  142. WATSON KE, Lee AL, Dwyer TJ, McKeough ZJ, et al
    Applying the treatable traits approach in bronchiectasis-A scoping review of traits, measurements and treatments implemented by allied health professionals and nurses.
    Respir Med. 2023 Dec 21:107503. doi: 10.1016/j.rmed.2023.107503.
    >> Share

  143. MIR FAKHRAEI R, Lindberg E, Benediktsdottir B, Svanes C, et al
    Gastroesophageal reflux and snoring are related to asthma and respiratory symptoms: Results from a Nordic longitudinal population survey.
    Respir Med. 2023 Dec 13:107495. doi: 10.1016/j.rmed.2023.107495.
    >> Share

  144. RITCHEY KC, Yohannes AM, Locke ER, Chen S, et al
    Association between self-reported falling risk and risk of hospitalization for patients with chronic obstructive pulmonary disease.
    Respir Med. 2023;220:107466.
    >> Share

  145. XIA J, Yang H, Zhan Q, Fan Y, et al
    High-flow nasal cannula may prolong the length of hospital stay in patients with hypercapnic acute COPD exacerbation.
    Respir Med. 2023;220:107465.
    >> Share

  146. SUN Y, Jiang F, Li R, Xiao L, et al
    The future landscape of immunology in COPD: A bibliometric analysis.
    Respir Med. 2023;220:107462.
    >> Share

  147. LLAMAS-SAEZ C, Saez-Vaquero T, Jimenez-Garcia R, Lopez-de-Andres A, et al
    Physical activity among adults with chronic obstructive pulmonary disease in Spain (2014-2020): Temporal trends, sex differences, and associated factors.
    Respir Med. 2023;220:107458.
    >> Share

  148. CHAIWONG W, Deesomchok A, Pothirat C, Duangjit P, et al
    Impact of the new European respiratory (ERS)/American Thoracic Society (ATS) pulmonary function test interpretation guidelines 2021 on the interpretation of bronchodilator responsiveness in subjects with airway obstruction.
    Respir Med. 2023;220:107460.
    >> Share

  149. VIANA SMDNR, de Bruin VMS, Vasconcelos RS, Nogueira ANC, et al
    Melatonin supplementation enhances pulmonary rehabilitation outcomes in COPD: a randomized, double-blind, placebo-controlled study.
    Respir Med. 2023;220:107441.
    >> Share

  150. ANANDAN J, Dwivedi DP, Govindaraj V
    Clinical phenotypes of COPD and their impact on quality of life: A cross-sectional study.
    Respir Med. 2023;220:107452.
    >> Share

  151. SUN Y, Zhang Y, Bai W, Liu X, et al
    Relationship between depression severity and respiratory symptoms in US adults: A national cross-sectional study.
    Respir Med. 2023;220:107451.
    >> Share

  152. QUADFLIEG K, Machado A, de Lima FF, Dederen A, et al
    Physical status, symptoms and health-related quality of life during a severe exacerbation of COPD: Recovery and discriminative capacity for future events.
    Respir Med. 2023;220:107437.
    >> Share

  153. TSUI AYY, Chau RMW, Cheing GLY, Mok TYW, et al
    Effect of chest wall mobilization on respiratory muscle function in patients with severe chronic obstructive pulmonary disease (COPD): A randomized controlled trial.
    Respir Med. 2023;220:107436.
    >> Share

    November 2023
  154. FREELS L, Herman A, Lukas S, Chan AHY, et al
    Asthma control and associated risk factors among adults with current asthma: Findings from 2019 behavioral risk factor surveillance system asthma call-back survey.
    Respir Med. 2023 Nov 25:107479. doi: 10.1016/j.rmed.2023.107479.
    >> Share

  155. ROCHE N, Yorgancioglu A, Cruz AA, Garcia G, et al
    Systematic literature review of traits and outcomes reported in randomised controlled trials of asthma with regular dosing of inhaled corticosteroids with short-acting beta(2)-agonist reliever, as-needed ICS/formoterol, or ICS/formoterol maintenance a
    Respir Med. 2023 Nov 24:107478. doi: 10.1016/j.rmed.2023.107478.
    >> Share

  156. MATTILA T, Vasankari T, Herse F, Leskela RL, et al
    Contrasting healthcare costs of COPD and asthma in elderly.
    Respir Med. 2023 Nov 21:107477. doi: 10.1016/j.rmed.2023.107477.
    >> Share

  157. URDOVA V, Rogers L, Jesenak M, Seys SF, et al
    Real-life studies and registries of severe asthma: The advent of digital technology.
    Respir Med. 2023 Nov 3:107429. doi: 10.1016/j.rmed.2023.107429.
    >> Share

  158. EPELBAUM O, Gemoets DE
    Good COP or bad COP: How much steroid is enough to avoid relapse?
    Respir Med. 2023;218:107413.
    >> Share

  159. LIM JU, Park S, Yoon JH, Lee SE, et al
    Efficacy of inhaled tiotropium add-on to budesonide/formoterol in patients with bronchiolitis obliterans developing after hematopoietic stem cell transplantation.
    Respir Med. 2023;218:107410.
    >> Share

  160. KIM YS, Hwang YI, Lee JH, Park YB, et al
    Clinical significance of normalized airflow obstruction in patients with chronic obstructive pulmonary disease.
    Respir Med. 2023;218:107398.
    >> Share

  161. MEHTA GD, Arroyo AC, Zhu Z, Espinola JA, et al
    Association between severe bronchiolitis in infancy and age 6-year lung function.
    Respir Med. 2023;218:107401.
    >> Share

  162. SUN Y, Molins E, Daoud SZ, Trivedi R, et al
    Efficacy and safety of aclidinium/formoterol versus monotherapies and aclidinium versus placebo in Chinese and other Asian patients with moderate-to-severe COPD: The AVANT Phase 3 study.
    Respir Med. 2023;218:107393.
    >> Share

  163. WILDE LJ, Percy C, Clark C, Ward G, et al
    Views and experiences of healthcare practitioners supporting people with COPD who have used activity monitors: "More than just steps".
    Respir Med. 2023;218:107395.
    >> Share

  164. ATSUMI K, Hisakane K, Mikami E, Suzuki T, et al
    Minimal effective dose of maintenance steroid therapy for relapse of cryptogenic organizing pneumonia.
    Respir Med. 2023;218:107390.
    >> Share

  165. CHERIAN M, Adam V, Ross B, Bourbeau J, et al
    Mortality in individuals with COPD on long-term home non-invasive ventilation.
    Respir Med. 2023;218:107378.
    >> Share

  166. BRUSSELLE G, Himpe U, Fievez P, Leys M, et al
    Evolving to a single inhaler extrafine LABA/LAMA/ICS - Inhalation technique and adherence at the heart of COPD patient care (TRIVOLVE).
    Respir Med. 2023;218:107368.
    >> Share

  167. ICHIKAWA T, Tajiri S, Yokoba M, Horimizu Y, et al
    Sniff and reverse-sniff nasal respiratory pressures after exacerbation of chronic obstructive pulmonary disease: A single-center prospective study.
    Respir Med. 2023;219:107438.
    >> Share

  168. MATERA MG, Rinaldi B, Ambrosio C, Cazzola M, et al
    Is it preferable to administer a bronchodilator once- or twice-daily when treating COPD?
    Respir Med. 2023;219:107439.
    >> Share

  169. QU Y, Gong Y, Li L, Song Y, et al
    Atomization efficacy of a novel micro-dose mesh nebulizer (CVS-100) versus the traditional mesh nebulizer (M102) in adults with chronic obstructive pulmonary disease: A randomized non-inferiority clinical trial.
    Respir Med. 2023;219:107434.
    >> Share

  170. MENESES-ECHAVEZ JF, Chavez Guapo N, Loaiza-Betancur AF, Machado A, et al
    Pulmonary rehabilitation for acute exacerbations of COPD: A systematic review.
    Respir Med. 2023;219:107425.
    >> Share

  171. BLONDEEL A, Hermans F, Breuls S, Wuyts M, et al
    Factors associated to physical activity in patients with COPD: An ecological approach.
    Respir Med. 2023;219:107424.
    >> Share

  172. CESTELLI L, Gulsvik A, Johannessen A, Stavem K, et al
    Reduced lung function and cause-specific mortality: A population-based study of Norwegian men followed for 26 years.
    Respir Med. 2023;219:107421.
    >> Share

  173. DE VOS R, Hicks A, Lomax M, Mackenzie H, et al
    A systematic review of methods of scoring inhaler technique.
    Respir Med. 2023;219:107430.
    >> Share

  174. PITRE T, Abbasi S, Su J, Mah J, et al
    Home high flow nasal cannula for chronic hypercapnic respiratory failure in COPD: A systematic review and meta-analysis.
    Respir Med. 2023;219:107420.
    >> Share

  175. OTSUKA J, Yoshizawa S, Kudo K, Osoreda H, et al
    Clinical features of relapsed connective tissue disease-associated organizing pneumonia.
    Respir Med. 2023;219:107419.
    >> Share

  176. LAVORINI F, Usmani OS, Salvi S, Rote K, et al
    A narrative review on the Synchrobreathe: A novel breath-actuated pressurised metered-dose inhaler for the treatment of obstructive airway diseases.
    Respir Med. 2023;219:107435.
    >> Share

    October 2023
  177. RENNER A, Stoshikj S, Pohl W, Bal C, et al
    Characterization of Austrian severe asthma patients.
    Respir Med. 2023 Oct 10:107427. doi: 10.1016/j.rmed.2023.107427.
    >> Share

  178. HENRY C, Biardel S, Boucher M, Godbout K, et al
    Bronchial thermoplasty attenuates bronchodilator responsiveness.
    Respir Med. 2023;217:107340.
    >> Share

  179. AXELSSON M, Backman H, Nwaru BI, Stridsman C, et al
    Underdiagnosis and misclassification of COPD in Sweden - A Nordic Epilung study.
    Respir Med. 2023;217:107347.
    >> Share

  180. PEREZ T, Roche N, Nunes H, Burgel PR, et al
    Dyspnea-induced Limitation (DYSLIM), a new self-administered concise questionnaire to evaluate dyspnea-related activity limitation in chronic respiratory diseases.
    Respir Med. 2023;217:107309.
    >> Share

  181. SHIMADA T, Chubachi S, Otake S, Sakurai K, et al
    Differential impacts between fat mass index and fat-free mass index on patients with COPD.
    Respir Med. 2023;217:107346.
    >> Share

    September 2023
  182. ROGERS L, Jesenak M, Bjermer L, Hanania NA, et al
    Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient.
    Respir Med. 2023 Sep 28:107414. doi: 10.1016/j.rmed.2023.107414.
    >> Share

  183. ITO M, Furuuchi K, Fujiwara K, Watanabe F, et al
    Multiple bacterial culture positivity reflects the severity and prognosis as bronchiectasis in Mycobacterium avium complex pulmonary disease.
    Respir Med. 2023;219:107417.
    >> Share

  184. WINSA-LINDMARK S, Stridsman C, Sahlin A, Hedman L, et al
    Severity of adult onset-asthma-a matter of blood neutrophils and severe obesity.
    Respir Med. 2023 Sep 26:107418. doi: 10.1016/j.rmed.2023.107418.
    >> Share

  185. KROES JA, Van Hal LHG, Van Dijk L, Zielhuis SW, et al
    The perceived waning of biologics in severe asthma.
    Respir Med. 2023 Sep 25:107416. doi: 10.1016/j.rmed.2023.107416.
    >> Share

  186. KLINGER JR, Wu B, Morland K, Classi P, et al
    Burden of pulmonary hypertension due to chronic obstructive pulmonary disease: Analysis of exacerbations and healthcare resource utilization in the United States.
    Respir Med. 2023 Sep 18:107412. doi: 10.1016/j.rmed.2023.107412.
    >> Share

  187. BROCK JM, Bohmker F, Schuster PU, Eberhardt R, et al
    Endobronchial lung volume reduction with valves reduces exacerbations in severe emphysema patients.
    Respir Med. 2023 Sep 4:107399. doi: 10.1016/j.rmed.2023.107399.
    >> Share

  188. VAARST JK, Sperling S, Dahl VN, Floe A, et al
    Lung abscess: Clinical characteristics of 222 Danish patients diagnosed from 2016 to 2021.
    Respir Med. 2023;216:107305.
    >> Share

  189. PELLEGRINO D, Casas-Recasens S, Faner R, Palange P, et al
    When GETomics meets aging and exercise in COPD.
    Respir Med. 2023;216:107294.
    >> Share

  190. BJORKLUND F, Palm A, Gorani JA, Ahmadi Z, et al
    Breathlessness and exercise performance to predict mortality in long-term oxygen therapy - The population-based DISCOVERY study.
    Respir Med. 2023;216:107306.
    >> Share

    August 2023
  191. MASPERO JF, Shafazand S, Cole J, Pavord ID, et al
    Dupilumab efficacy in high sleep disturbance management among patients with type 2 asthma.
    Respir Med. 2023 Aug 31:107344. doi: 10.1016/j.rmed.2023.107344.
    >> Share

  192. COTTINI M, Bondi B, Bagnasco D, Braido F, et al
    Impulse oscillometry defined small airway dysfunction in asthmatic patients with normal spirometry: Prevalence, clinical associations, and impact on asthma control.
    Respir Med. 2023 Aug 16:107391. doi: 10.1016/j.rmed.2023.107391.
    >> Share

  193. ASSAF S, Stenberg H, Jesenak M, Tarasevych SP, et al
    Asthma in the era of COVID-19.
    Respir Med. 2023 Aug 9:107373. doi: 10.1016/j.rmed.2023.107373.
    >> Share

  194. DIERICK BJH, Achterbosch M, Eikholt AA, Been-Buck S, et al
    Electronic monitoring with a digital smart spacer to support personalized inhaler use education in patients with asthma: The randomized controlled OUTERSPACE trial.
    Respir Med. 2023 Aug 5:107376. doi: 10.1016/j.rmed.2023.107376.
    >> Share

  195. RODRIGUEZ GARCIA C, Ruano-Ravina A, Perez Rios M, Martin Gisbert L, et al
    Clinical characteristics of chronic obstructive pulmonary disease in never-smokers: A systematic review.
    Respir Med. 2023;214:107284.
    >> Share

  196. CAZZOLA M, Blasi F
    There is still no established and accepted definition of COPD.
    Respir Med. 2023;214:107262.
    >> Share

  197. D'ANNA SE, Dossena F, Gnemmi I, Brun P, et al
    Bacterial load and related innate immune response in the bronchi of rapid decliners with chronic obstructive pulmonary disease.
    Respir Med. 2023;215:107297.
    >> Share

  198. QAISAR R, Karim A, Muhammad T, Alkahtani SA, et al
    Degradation of neuromuscular junction contributes to muscle weakness but not physical compromise in chronic obstructive pulmonary disease patients taking lipids-lowering medications.
    Respir Med. 2023;215:107298.
    >> Share

  199. VAN DER MOLEN MC, Slebos DJ, Augustijn SWS, Kerstjens HAM, et al
    The minimal important difference of the constant work rate cycle test in severe COPD.
    Respir Med. 2023;215:107265.
    >> Share

  200. KAMINSKY DA, He J, Henderson R, Dixon AE, et al
    Bronchodilator response does not associate with asthma control or symptom burden among patients with poorly controlled asthma.
    Respir Med. 2023 Aug 1:107375. doi: 10.1016/j.rmed.2023.107375.
    >> Share

    July 2023
  201. YORGANCIOGLU A, Cruz AA, Garcia G, Lavoie KL, et al
    A network meta-analysis of the association between patient traits and response to regular dosing with ICS/long-acting beta(2)-agonist plus short-acting beta(2) agonist reliever or maintenance and reliever therapy for asthma.
    Respir Med. 2023 Jul 29:107377. doi: 10.1016/j.rmed.2023.107377.
    >> Share

  202. DIAMANT Z, Jesenak M, Hanania NA, Heaney LG, et al
    EUFOREA pocket guide on the diagnosis and management of asthma: An educational and practical tool for general practitioners, non-respiratory physicians, paramedics and patients.
    Respir Med. 2023 Jul 28:107361. doi: 10.1016/j.rmed.2023.107361.
    >> Share

  203. JESENAK M, Durdik P, Oppova D, Franova S, et al
    Dysfunctional mucociliary clearance in asthma and airway remodeling - New insights into an old topic.
    Respir Med. 2023 Jul 27:107372. doi: 10.1016/j.rmed.2023.107372.
    >> Share

  204. CHAN AHY, Tomlin A, Beyene K, Harrison J, et al
    Asthma exacerbations in New Zealand 2010-2019: A national population-based study.
    Respir Med. 2023;217:107365.
    >> Share

  205. PONTE EV, Rocha DGD, Guinossi RM, Bertoche L, et al
    Evaluating the relationship between the type of rescue medication and the adequacy of asthma maintenance therapy.
    Respir Med. 2023 Jul 18:107364. doi: 10.1016/j.rmed.2023.107364.
    >> Share

  206. DIAMANT Z, Seys SF, Rogers L, Hanania NA, et al
    Integrating innovations in asthma research into clinical practice.
    Respir Med. 2023;217:107345.
    >> Share

  207. BAYDUR A, Barbers R, May D
    Effect of bronchial thermoplasty on static and dynamic lung compliance and resistance in patients with severe persistent asthma.
    Respir Med. 2023 Jul 8:107341. doi: 10.1016/j.rmed.2023.107341.
    >> Share

  208. GEPHINE S, Fry S, Margoline E, Gicquello A, et al
    Home-based pulmonary rehabilitation for adults with severe asthma exposed to psychosocial chronic stressors.
    Respir Med. 2023 Jul 7:107349. doi: 10.1016/j.rmed.2023.107349.
    >> Share

  209. PORTACCI A, Iorillo I, Quaranta VN, Maselli L, et al
    Severe asthma clinical remission after biologic treatment with anti-IL4/IL13: A real-life experience.
    Respir Med. 2023;217:107348.
    >> Share

  210. BAKHT MUHAMMAD
    Comment on: Identifying responders and exploring mechanisms of action of the endobronchial coil treatment for emphysema.
    Respir Med. 2023 Jul 1:107343. doi: 10.1016/j.rmed.2023.107343.
    >> Share

    June 2023
  211. KOSTIKAS K, Maspero JF, Chapman KR, Mezzi K, et al
    Efficacy of mometasone/indacaterol/glycopyrronium in patients with inadequately controlled asthma with respect to baseline eosinophil count: Post hoc analysis of IRIDIUM study.
    Respir Med. 2023 Jun 29:107334. doi: 10.1016/j.rmed.2023.107334.
    >> Share

  212. VAKHSHOORZADEH J, Lui JK, Sangani RA, Trojanowski MA, et al
    Emphysema and interstitial lung disease in systemic sclerosis-related pulmonary hypertension.
    Respir Med. 2023;216:107333.
    >> Share

  213. MOHAN A, Lugogo NL
    Mild asthma: Lessons learned and remaining questions.
    Respir Med. 2023 Jun 14:107326. doi: 10.1016/j.rmed.2023.107326.
    >> Share

  214. ADRISH M, Akuthota P
    Approach to non-type 2 asthma.
    Respir Med. 2023 Jun 10:107327. doi: 10.1016/j.rmed.2023.107327.
    >> Share

  215. NISHIYAMA H, Kanemitsu Y, Hara J, Fukumitsu K, et al
    Bronchial thermoplasty improves cough hypersensitivity and cough in severe asthmatics.
    Respir Med. 2023 Jun 10:107303. doi: 10.1016/j.rmed.2023.107303.
    >> Share

  216. PANETTIERI RA, Lugogo N, Moore WC, Chipps BE, et al
    Real-world effectiveness of benralizumab in US subspecialist-treated adults with severe asthma: Findings from CHRONICLE.
    Respir Med. 2023 Jun 6:107285. doi: 10.1016/j.rmed.2023.107285.
    >> Share

  217. STURESSON A, Hedman L, Stridsman C, Lindberg A, et al
    Obesity associates with increased all-cause and cardiovascular mortality in adults with asthma.
    Respir Med. 2023 Jun 4:107301. doi: 10.1016/j.rmed.2023.107301.
    >> Share

  218. SELBERG S, Karlsson Sundbaum J, Konradsen JR, Backman H, et al
    Multiple manifestations of uncontrolled asthma increase the risk of severe COVID-19.
    Respir Med. 2023;216:107308.
    >> Share

  219. KISIEL MA, Sedvall M, Malinovschi A, Franklin KA, et al
    Inflammatory bowel disease and asthma. Results from the RHINE study.
    Respir Med. 2023 Jun 2:107307. doi: 10.1016/j.rmed.2023.107307.
    >> Share

  220. PETERSSON SJOGREN M, Karedal M, Broberg K, Assarsson E, et al
    Sensitive methods for assessment of lung health in welders and controls.
    Respir Med. 2023;212:107244.
    >> Share

  221. ESTEBAN C, Anton-Ladislao A, Aramburu A, Chasco L, et al
    Change in physical activity related to admission for exacerbation in COPD patients.
    Respir Med. 2023;212:107236.
    >> Share

  222. AARHUS L, Sand M, Engdahl B
    COPD and 20-year hearing decline: The HUNT cohort study.
    Respir Med. 2023;212:107221.
    >> Share

  223. ASAI N, Ohkuni Y, Ohashi W, Kaneko N, et al
    Modified MRC assessment and FEV1.0 can predict frequent acute exacerbation of COPD: An observational prospective cohort study at a single-center in Japan.
    Respir Med. 2023;212:107218.
    >> Share

  224. PORPODIS K, Bartziokas K, Chatziapostolou P, Korkontzelou A, et al
    "Extrafine single inhaler triple therapy effect on health status, lung function and adherence in COPD patients: A Panhellenic prospective non-interventional study - The TRIBUNE study".
    Respir Med. 2023;212:107219.
    >> Share

  225. DE MIGUEL-DIEZ J, Lopez-de-Andres A, Jimenez-Garcia R, Hernandez-Barrera V, et al
    Trends in prevalence and the effects on hospital outcomes of dementia in patients hospitalized with acute COPD exacerbation.
    Respir Med. 2023;212:107223.
    >> Share

    May 2023
  226. BRUNN B, Hapfelmeier A, Jorres RA, Schultz K, et al
    Development of a diagnostic score using FeNO and symptoms to predict asthma.
    Respir Med. 2023 May 29:107299. doi: 10.1016/j.rmed.2023.107299.
    >> Share

  227. LIANG Y, Zhang J, Bai S, Du S, et al
    Short-term and long-term effects of cesarean section on asthma and wheezing: A cohort study and meta-analysis.
    Respir Med. 2023 May 29:107300. doi: 10.1016/j.rmed.2023.107300.
    >> Share

  228. FONG KY, Zhao JJ, Syn NL, Nair P, et al
    Comparing bronchial thermoplasty with biologicals for severe asthma: Systematic review and network meta-analysis.
    Respir Med. 2023 May 29:107302. doi: 10.1016/j.rmed.2023.107302.
    >> Share

  229. LOZANO-ESPINOSA M, Antolin-Amerigo D, Riera J, Gordo Vidal F, et al
    Extracorporeal membrane oxygenation (ECMO) and beyond in near fatal asthma: A comprehensive review.
    Respir Med. 2023;215:107246.
    >> Share

  230. KHAN S, Ouaalaya EH, Chauveau AD, Scherer E, et al
    Whispers of change in preschool asthma phenotypes: Findings in the French ELFE cohort.
    Respir Med. 2023 May 22:107263. doi: 10.1016/j.rmed.2023.107263.
    >> Share

  231. BOUSSO A, Chuffart C, Leroy M, Gicquello A, et al
    Severity and phenotypes of dyspnea in asthma: Impact of comorbidities.
    Respir Med. 2023 May 20:107276. doi: 10.1016/j.rmed.2023.107276.
    >> Share

  232. KHORASANI AM, Mohammadi B, Saghafi MR, Mohammadi S, et al
    The association between MUC5AC and MUC5B genes expression and remodeling progression in severe neutrophilic asthma: A direct relationship.
    Respir Med. 2023 May 3:107260. doi: 10.1016/j.rmed.2023.107260.
    >> Share

  233. TOUMPANAKIS D, Usmani OS
    Small airways disease in patients with alpha-1 antitrypsin deficiency.
    Respir Med. 2023;211:107222.
    >> Share

  234. LAORDEN D, Zamarron E, Romero D, Dominguez-Ortega J, et al
    Evaluation of FEOS score and super-responder criteria in a real-life cohort treated with anti-IL5/IL5R.
    Respir Med. 2023;211:107216.
    >> Share

  235. BASHIR MBA, Basna R, Hedman L, Backman H, et al
    Interaction of smoking and social status on the risk of respiratory outcomes in a Swedish adult population: A Nordic Epilung study.
    Respir Med. 2023;211:107192.
    >> Share

  236. MORRIS JR, Harrison SL, Robinson J, Martin D, et al
    Non-pharmacological and non-invasive interventions for chronic pain in people with chronic obstructive pulmonary disease: A systematic review without meta-analysis.
    Respir Med. 2023;211:107191.
    >> Share

  237. BRAY K, Bodduluri S, Kim YI, Sthanam V, et al
    Idiopathic pulmonary fibrosis is more strongly associated with coronary artery disease than chronic obstructive pulmonary disease.
    Respir Med. 2023;211:107195.
    >> Share

  238. AN Q, Sandlund M, Agnello D, McCaffrey L, et al
    A scoping review of co-creation practice in the development of non-pharmacological interventions for people with Chronic Obstructive Pulmonary Disease: A health CASCADE study.
    Respir Med. 2023;211:107193.
    >> Share

    April 2023
  239. PRICE OJ, Simpson AJ
    Exercise and asthma - trigger or treatment?
    Respir Med. 2023;213:107247.
    >> Share

  240. ZHU D, Dai H, Zhu H, Fang Y, et al
    Identification of frequent acute exacerbations phenotype in COPD patients based on imaging and clinical characteristics.
    Respir Med. 2023;209:107150.
    >> Share

  241. GU W, Tian Z, Tian W, Song Y, et al
    Association of rest-activity circadian rhythm with chronic respiratory diseases, a cross-section survey from NHANES 2011-2014.
    Respir Med. 2023;209:107147.
    >> Share

  242. ROODENBURG SA, Slebos DJ, van Dijk M, Koster TD, et al
    Improved exercise capacity results in a survival benefit after endobronchial valve treatment.
    Respir Med. 2023;210:107175.
    >> Share

  243. FARROKHI M, Ahadiat SA
    Stability of distinct symptom experiences in patients with COPD.
    Respir Med. 2023;210:107166.
    >> Share

    March 2023
  244. KISIEL MA, Arnfelt O, Lindberg E, Jogi O, et al
    Association between abdominal and general obesity and respiratory symptoms, asthma and COPD. Results from the RHINE study.
    Respir Med. 2023;211:107213.
    >> Share

  245. FLUME PA, Basavaraj A, Garcia B, Winthrop K, et al
    Towards development of evidence to inform recommendations for the evaluation and management of bronchiectasis.
    Respir Med. 2023 Mar 15:107217. doi: 10.1016/j.rmed.2023.107217.
    >> Share

  246. VAN DER BURG N, Tufvesson E
    Is asthma's heterogeneity too vast to use traditional phenotyping for modern biologic therapies?
    Respir Med. 2023 Mar 14:107211. doi: 10.1016/j.rmed.2023.107211.
    >> Share

  247. VAN ZYL-SMIT RN, Kerstjens HA, Maspero JF, Kostikas K, et al
    Efficacy of once-daily, single-inhaler, fixed-dose combination of mometasone/indacaterol/glycopyrronium in patients with asthma with or without persistent airflow limitation: Post hoc analysis from the IRIDIUM study.
    Respir Med. 2023 Mar 9:107172. doi: 10.1016/j.rmed.2023.107172.
    >> Share

  248. WANG H, Liu Q, Liu L, Cao J, et al
    High-intensity interval training improves the outcomes of patients with chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials.
    Respir Med. 2023;208:107128.
    >> Share

  249. TRAN TV, Kinney GL, Comellas A, Hoth KF, et al
    Prevalence of abnormal spirometry in individuals with a smoking history and no known obstructive lung disease.
    Respir Med. 2023;208:107126.
    >> Share

  250. TSAI CL, Chang WP, Lin YK, Ho SC, et al
    Physical frailty related to cognitive impairment and COPD exacerbation: A cross-sectional study.
    Respir Med. 2023;208:107129.
    >> Share

  251. DONOHUE JF, Ferguson GT, Ohar JA, Lombardi DA, et al
    Improvements in health status with revefenacin, a once-daily, nebulized, long-acting muscarinic antagonist for chronic obstructive pulmonary disease.
    Respir Med. 2023;208:107123.
    >> Share

    February 2023
  252. BAKAKOS P, Tryfon S, Palamidas A, Mathioudakis N, et al
    Patient characteristics and eligibility for biologics in severe asthma: Results from the Greek cohort of the RECOGNISE "real world" study.
    Respir Med. 2023;210:107170.
    >> Share

  253. ERJEFALT JS
    Anatomical and histopathological approaches to asthma phenotyping.
    Respir Med. 2023 Feb 21:107168. doi: 10.1016/j.rmed.2023.107168.
    >> Share

  254. MCSHANE PJ, Choate R, Johnson M, Maselli DJ, et al
    Racial and ethnic differences in patients enrolled in the national bronchiectasis and nontuberculous mycobacteria research registry.
    Respir Med. 2023;209:107167.
    >> Share

  255. COTTINI M, Lombardi C, Comberiati P, Landi M, et al
    Small airway dysfunction in asthmatic patients treated with as-needed SABA monotherapy: A perfect storm.
    Respir Med. 2023 Feb 14:107154. doi: 10.1016/j.rmed.2023.107154.
    >> Share

  256. DESORMEAU B, Smyrnova A, Drouin O, Ducharme FM, et al
    Oscillometry to support clinical assessment in asthmatic preschoolers: Real-life impact.
    Respir Med. 2023 Feb 6:107148. doi: 10.1016/j.rmed.2023.107148.
    >> Share

  257. SORENSEN KG, Oymar K, Jonsson G, Dalen I, et al
    Are BMI and adipokines associated with asthma, atopy and lung function in young adults previously hospitalized for bronchiolitis?
    Respir Med. 2023 Feb 6:107149. doi: 10.1016/j.rmed.2023.107149.
    >> Share

  258. GARCIA-RIO F, Miravitlles M, Soriano JB, Cosio BG, et al
    Dissociation between physical capacity and daily physical activity in COPD patients. A population-based approach.
    Respir Med. 2023;207:107115.
    >> Share

  259. AGUSTI A, Ambrosino N, Blackstock F, Bourbeau J, et al
    COPD: Providing the right treatment for the right patient at the right time.
    Respir Med. 2023;207:107041.
    >> Share

  260. O'HOSKI S, Kuspinar A, Richardson J, Wald J, et al
    Responsiveness of the late life disability instrument to pulmonary rehabilitation in people with COPD.
    Respir Med. 2023;207:107113.
    >> Share

  261. HILVERING B, Koenderman L
    Quality over quantity; eosinophil activation status will deepen the insight into eosinophilic diseases.
    Respir Med. 2023;207:107094.
    >> Share

    January 2023
  262. DIAMANT Z, van Maaren M, Muraro A, Jesenak M, et al
    Allergen immunotherapy for allergic asthma - The future seems bright.
    Respir Med. 2023 Jan 23:107125. doi: 10.1016/j.rmed.2023.107125.
    >> Share

  263. POMPE E, Kwee AK, Tejwani V, Siddharthan T, et al
    Imaging-derived biomarkers in Asthma: Current status and future perspectives.
    Respir Med. 2023 Jan 23:107130. doi: 10.1016/j.rmed.2023.107130.
    >> Share

  264. AL-SHUWELI S, Landt E, Ellervik C, Poulsen HE, et al
    Risk of asthma in offspring of asthmatic fathers versus mothers: A population-based study of 21,000 individuals in Denmark.
    Respir Med. 2023;207:107116.
    >> Share

  265. MACNEIL A, Li G, Jiang Y, de Groh M, et al
    Incident and recurrent depression among older adults with asthma during the COVID-19 pandemic: Findings from the Canadian Longitudinal Study on Aging.
    Respir Med. 2023 Jan 11:107003. doi: 10.1016/j.rmed.2022.107003.
    >> Share

  266. LOSOL P, Sokolowska M, Chang YS
    Interactions between microbiome and underlying mechanisms in asthma.
    Respir Med. 2023 Jan 11:107118. doi: 10.1016/j.rmed.2023.107118.
    >> Share

  267. LIU Y, Li P, Jiang T, Li Y, et al
    Epidermal growth factor receptor in asthma: A promising therapeutic target?
    Respir Med. 2023;207:107117.
    >> Share

  268. RUAN H, Zhang H, Wang J, Zhao H, et al
    Readmission rate for acute exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Respir Med. 2023;206:107090.
    >> Share

  269. FLORA S, Marques A, Hipolito N, Morais N, et al
    Test-retest reliability, agreement and construct validity of the International Physical Activity Questionnaire short-form (IPAQ-sf) in people with COPD.
    Respir Med. 2023;206:107087.
    >> Share

  270. SOUTO-MIRANDA S, Rocha V, Mendes MA, Simao P, et al
    The presence of extra-pulmonary treatable traits increases the likelihood of responding to pulmonary rehabilitation.
    Respir Med. 2023;206:107086.
    >> Share

  271. MYERS LC, Murray R, Donato B, Liu VX, et al
    Risk of hospitalization in a sample of COVID-19 patients with and without chronic obstructive pulmonary disease.
    Respir Med. 2023;206:107064.
    >> Share

  272. HARTMAN JE, Herth FJF, Shah P, Pison C, et al
    Computed tomographic airway morphology after targeted lung denervation treatment in COPD.
    Respir Med. 2023;206:107059.
    >> Share

    December 2022
  273. MATTILA T, Vasankari T, Kauppi P, Mazur W, et al
    Mortality of asthma, COPD, and asthma-COPD overlap during an 18-year follow up.
    Respir Med. 2022 Dec 31:107112. doi: 10.1016/j.rmed.2022.107112.
    >> Share

  274. THEODORO EE, Rocha DGD, Bertolino JR, Guinossi RM, et al
    Evaluating the effect of antidepressants on the relationship between depression and asthma.
    Respir Med. 2022;207:107099.
    >> Share

  275. LOUIS G, Schleich F, Louis R, Guillaume M, et al
    How respiratory symptoms impact asthma-related quality of life in mild asthmatics.
    Respir Med. 2022;207:107098.
    >> Share

  276. RENNER A, Marth K, Breyer-Kohansal R, Pohl W, et al
    Combined analysis of five non-interventional studies of the effectiveness, tolerability, and safety of the extrafine fixed dose beclomethasone/formoterol combination in the treatment of asthma in Austria.
    Respir Med. 2022;207:107097.
    >> Share

  277. LI J, Price KR, Weeda ER, Garner SS, et al
    Trends in prescribing as-needed inhaled corticosteroid (ICS)-Formoterol for patients with asthma.
    Respir Med. 2022;207:107096.
    >> Share

  278. LAORDEN D, Dominguez-Ortega J, Carpio C, Barranco P, et al
    Long COVID outcomes in an asthmatic cohort and its implications for asthma control.
    Respir Med. 2022 Dec 16:107092. doi: 10.1016/j.rmed.2022.107092.
    >> Share

  279. GOUDARZI H, Kimura H, Kimura H, Makita H, et al
    Association of serum CC16 levels with eosinophilic inflammation and respiratory dysfunction in severe asthma.
    Respir Med. 2022;206:107089.
    >> Share

  280. ROTHE T, von Garnier C, Bridevaux PO, Charbonnier F, et al
    The clinical features of asthma exacerbations in early-onset and eosinophilic late-onset asthma may differ significantly.
    Respir Med. 2022;206:107067.
    >> Share

  281. BARDSLEY S, Criner GJ, Halpin DMG, Han MK, et al
    Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis.
    Respir Med. 2022;205:107040.
    >> Share

  282. CAZZOLA M, Matera MG
    Clinically important deterioration: a composite tool for managing patients with COPD.
    Respir Med. 2022;205:107054.
    >> Share

  283. STEPHENSON H, Roberts M, Klimkeit E, Smith T, et al
    Uncovering undernutrition in chronic obstructive pulmonary disease: Beyond body mass index.
    Respir Med. 2022;205:107026.
    >> Share

  284. WU J, Zhao X, Xiao C, Xiong G, et al
    The role of lung macrophages in chronic obstructive pulmonary disease.
    Respir Med. 2022;205:107035.
    >> Share

    November 2022
  285. THELEN JC, van Zelst CM, van Brummelen SE, Rauh S, et al
    Efficacy and safety of dupilumab as add-on therapy for patients with severe asthma: A real-world Dutch cohort study.
    Respir Med. 2022;206:107058.
    >> Share

  286. ROCHE N, Nadif R, Fabry-Vendrand C, Pillot L, et al
    Asthma burden according to treatment steps in the French population-based cohort CONSTANCES.
    Respir Med. 2022;206:107057.
    >> Share

  287. ALIBERTI S, Gramegna A, Zucchetti S, Simonetta E, et al
    Respiratory viruses in stable bronchiectasis: A multicenter evaluation in Northern Italy.
    Respir Med. 2022;205:107056.
    >> Share

  288. PLEASANTS RA, Chan AH, Mosnaim G, Costello RW, et al
    Integrating digital inhalers into clinical care of patients with asthma and chronic obstructive pulmonary disease.
    Respir Med. 2022;205:107038.
    >> Share

  289. SUNJAYA A, Poulos L, Reddel H, Jenkins C, et al
    Qualitative validation of the modified Medical Research Council (mMRC) dyspnoea scale as a patient-reported measure of breathlessness severity.
    Respir Med. 2022;203:106984.
    >> Share

  290. KOSTER TD, Eberhardt R, Huebner RH, Valipour A, et al
    A multicenter, prospective, single-arm clinical investigation of a modified staged treatment algorithm using the AeriSeal system - The STAGE trial.
    Respir Med. 2022;203:106989.
    >> Share

  291. GOGOU E, Hatzoglou C, Zarogiannis SG, Siachpazidou D, et al
    Are younger COPD patients adequately vaccinated for influenza and pneumococcus?
    Respir Med. 2022;203:106988.
    >> Share

  292. HOSKOTE SS
    Corrected formula for rectangular area ratio (RAR), a parameter used to quantify airflow limitation on expiratory flow-volume curves.
    Respir Med. 2022;204:107032.
    >> Share

  293. MUKHERJEE P, Bhattacharya D, Esquinas AM, Mandal M, et al
    HFNC can bring the children with bronchiolitis off the ventilator earlier: Fact or fiction?
    Respir Med. 2022;204:107033.
    >> Share

  294. KAHNERT K, Jorres RA, Jobst B, Wielputz MO, et al
    Association of coronary artery calcification with clinical and physiological characteristics in patients with COPD: Results from COSYCONET.
    Respir Med. 2022;204:107014.
    >> Share

  295. SANSORES RH, Paulin-Prado P, Robles-Hernandez R, Montiel-Lopez F, et al
    Clinical and microbiological characteristics and inflammatory profile during an exacerbation of COPD due to biomass exposure. A comparison with COPD due to tobacco exposure.
    Respir Med. 2022;204:107010.
    >> Share

  296. MOCHIZUKI F, Tanabe N, Iijima H, Shimada T, et al
    Early chronic obstructive pulmonary disease: Associations of two spirometry criteria with clinical features.
    Respir Med. 2022;204:107011.
    >> Share

    October 2022
  297. MAIO S, Murgia N, Tagliaferro S, Angino A, et al
    The Italian severe/uncontrolled asthma registry (RItA): A 12-month clinical follow-up.
    Respir Med. 2022;205:107030.
    >> Share

  298. VAN DER PALEN J, Slade D, Rehal S, Verma M, et al
    A randomized, cross-over study comparing critical and overall errors, learning time, and preference of the ELLIPTA versus BREEZHALER dry powder inhalers in patients with asthma.
    Respir Med. 2022;205:107031.
    >> Share

  299. RYAN D, Keighley A, Jackson T
    Patient perspectives in asthma: Listening to and learning from a new paradigm in translational research.
    Respir Med. 2022;205:107013.
    >> Share

  300. CHAN KC, Au CT, Wong E, Chook P, et al
    Inferior endothelial function improved following optimisation of asthma control in children.
    Respir Med. 2022;204:107024.
    >> Share

  301. TOOBA R, Wu TD
    Obesity and asthma: A focused review.
    Respir Med. 2022;204:107012.
    >> Share

  302. CABALLERO-SEGURA FJ, Lopez-de-Andres A, Jimenez-Garcia R, de Miguel-Yanes JM, et al
    Trends in asthma hospitalizations among adults in Spain: Analysis of hospital discharge data from 2011 to 2020.
    Respir Med. 2022;204:107009.
    >> Share

  303. GHOSH S, Rihan M, Ahmed S, Pande AH, et al
    Immunomodulatory potential of apolipoproteins and their mimetic peptides in asthma: Current perspective.
    Respir Med. 2022;204:107007.
    >> Share

  304. PATRICIA DE SOUZA MENDES L, Parreira VF, Spencer LM, Zafiropoulos B, et al
    Glittre endurance test: A new test to assess the functional capacity of individuals with chronic obstructive pulmonary disease.
    Respir Med. 2022;202:106983.
    >> Share

  305. VITACCA M, Paneroni M, Spanevello A, Ceriana P, et al
    Effectiveness of pulmonary rehabilitation in individuals with Chronic Obstructive Pulmonary Disease according to inhaled therapy: The Maugeri study.
    Respir Med. 2022;202:106967.
    >> Share

  306. HINES SE, Gaitens JM, Brown CH, Glick DR, et al
    Self-reported respiratory outcomes associated with blast exposure in post 9/11 veterans.
    Respir Med. 2022;202:106963.
    >> Share

    September 2022
  307. MANEECHOTESUWAN K, Singh D, Fritscher LG, Dursunoglu N, et al
    Impact of inhaled fluticasone propionate/salmeterol on health-related quality of life in asthma: A network meta-analysis.
    Respir Med. 2022;203:106993.
    >> Share

  308. TRAN C, Singh GV, Haider E, Boylan C, et al
    Luminal mucus plugs are spatially associated with airway wall thickening in severe COPD and asthma: A single-centered, retrospective, observational study.
    Respir Med. 2022;202:106982.
    >> Share

  309. ROCHE N, Aggarwal B, Boucot I, Mittal L, et al
    The impact of inhaler technique on clinical outcomes in adolescents and adults with asthma: A systematic review.
    Respir Med. 2022;202:106949.
    >> Share

  310. SUNJAYA AP, Sengupta A, Martin A, Di Tanna GL, et al
    Efficacy of self-management mobile applications for patients with breathlessness: Systematic review and quality assessment of publicly available applications.
    Respir Med. 2022;201:106947.
    >> Share

  311. ODAJIU I, Covantsev S, Sivapalan P, Mathioudakis AG, et al
    Peripheral neuropathy: A neglected cause of disability in COPD - A narrative review.
    Respir Med. 2022;201:106952.
    >> Share

  312. CHRISTENSEN VL, Rustoen T, Thoresen M, Holm AM, et al
    Stability of distinct symptom experiences in patients with chronic obstructive pulmonary disease (COPD).
    Respir Med. 2022;201:106944.
    >> Share

  313. AMIN R, Maiya GA, Mohapatra AK, Acharya V, et al
    Effect of a home-based pulmonary rehabilitation program on functional capacity and health-related quality of life in people with interstitial lung disease - A randomized controlled trial protocol.
    Respir Med. 2022;201:106927.
    >> Share

  314. CHOI J, Park E, Park H, Kang D, et al
    Effect of high-flow nasal cannula on mechanical ventilator duration in bronchiolitis patients.
    Respir Med. 2022;201:106946.
    >> Share

  315. FINAMORE P, Lattanzi G, Pedone C, Poci S, et al
    Energy expenditure and intake in COPD: The extent of unnoticed unbalance by predicting REE.
    Respir Med. 2022;201:106951.
    >> Share

  316. DIERICK BJH, Been-Buck S, Klemmeier T, Hagedoorn P, et al
    Digital spacer data driven COPD inhaler adherence education: The OUTERSPACE proof-of-concept study.
    Respir Med. 2022;201:106940.
    >> Share

  317. SOUTO-MIRANDA S, Vaes AW, Gloeckl R, Grongstad A, et al
    International perspectives on outcome measurement in pulmonary rehabilitation of people with COPD: A qualitative study.
    Respir Med. 2022;201:106936.
    >> Share

  318. HAMAKAWA Y, Sato S, Tanabe N, Rhee CK, et al
    Non-respiratory symptom dominance is associated with depression in patients with chronic obstructive pulmonary disease.
    Respir Med. 2022;201:106895.
    >> Share

    August 2022
  319. DOLLIVER WR, Wang W, Nardelli P, Rahaghi FN, et al
    Pulmonary arterial pruning is associated with CT-derived bronchiectasis progression in smokers.
    Respir Med. 2022;202:106971.
    >> Share

  320. BOURDIN A, Virchow JC, Papi A, Lugogo NL, et al
    Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline.
    Respir Med. 2022;202:106938.
    >> Share

  321. TAJIRI S, Kondo T, Tanigaki T, Hibino M, et al
    Daily inhaled flow profiles and drug release from dry powder inhalers in patients with bronchial asthma.
    Respir Med. 2022;201:106950.
    >> Share

  322. CHAPMAN KR, Canonica GW, Lavoie KL, Nenasheva N, et al
    Patients' and physicians' perspectives on the burden and management of asthma: Results from the APPaRENT 2 study.
    Respir Med. 2022;201:106948.
    >> Share

  323. CANONICA GW, Spanevello A, de Llano LP, Domingo Ribas C, et al
    Is asthma control more than just an absence of symptoms? An expert consensus statement.
    Respir Med. 2022;202:106942.
    >> Share

  324. SOUTO-MIRANDA S, Antao J, Rodrigues G, Mendes MA, et al
    Cut-off of the one-minute sit-to-stand test to detect functional impairment in people with chronic obstructive pulmonary disease.
    Respir Med. 2022;199:106892.
    >> Share

  325. TRELA KC, Zajac P, Zhu M, Press VG, et al
    Health literacy and type of education intervention predicting post-education metered-dose inhaler misuse.
    Respir Med. 2022;200:106930.
    >> Share

  326. FRAZIER WD, DaVanzo JE, Dobson A, Heath S, et al
    Early Initiation of non-invasive ventilation at home improves survival and reduces healthcare costs in COPD patients with chronic hypercapnic respiratory failure: A retrospective cohort study.
    Respir Med. 2022;200:106920.
    >> Share

  327. MALTAIS F, Vogelmeier CF, Kerwin EM, Bjermer LH, et al
    Applying key learnings from the EMAX trial to clinical practice and future trial design in COPD.
    Respir Med. 2022;200:106918.
    >> Share

    July 2022
  328. HINE C, Desai M, Davies J, Sapey E, et al
    A systematic review of lung clearance index in non-cystic fibrosis, non-primary ciliary dyskinesia bronchiectasis.
    Respir Med. 2022;201:106937.
    >> Share

  329. ORLOVIC M, Magni T, Lukyanov V, Guerra I, et al
    Cost-effectiveness of single-inhaler extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium in patients with uncontrolled asthma in England.
    Respir Med. 2022;201:106934.
    >> Share

  330. LI M, Wen Ma Z, Jun Deng S, Oliver BG, et al
    Development and validation of a noninvasive prediction model for identifying eosinophilic asthma.
    Respir Med. 2022;201:106935.
    >> Share

  331. HENRY SL, Moore LE, Brotto AR, Rowland S, et al
    Systemic vascular health is compromised in both confirmed and unconfirmed asthma.
    Respir Med. 2022;200:106932.
    >> Share

  332. ALHABEEB FF, Whitmore GA, Vandemheen KL, FitzGerald JM, et al
    Disease burden in individuals with symptomatic undiagnosed asthma or COPD.
    Respir Med. 2022;200:106917.
    >> Share

  333. DALIN DA, Lokke A, Kristiansen P, Jensen C, et al
    A systematic review of blood eosinophils and continued treatment with inhaled corticosteroids in patients with COPD.
    Respir Med. 2022;198:106880.
    >> Share

  334. YOHANNES AM, Murri MB, Hanania NA, Regan EA, et al
    Depressive and anxiety symptoms in patients with COPD: A network analysis.
    Respir Med. 2022;198:106865.
    >> Share

  335. AL CHIKHANIE Y, Bailly S, Amroussa I, Veale D, et al
    Clustering of COPD patients and their response to pulmonary rehabilitation.
    Respir Med. 2022;198:106861.
    >> Share

  336. ZAFARI Z, Lee TY, Sadatsafavi M
    External validation of lung function predictions in real-world cohorts of COPD.
    Respir Med. 2022;198:106859.
    >> Share

    June 2022
  337. PATELLA V, Pelaia C, Zunno R, Pelaia G, et al
    Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemic.
    Respir Med. 2022;200:106916.
    >> Share

  338. LIU L, Zhang X, Zhang L, Liu Y, et al
    Reduced bronchodilator reversibility correlates with non-type 2 high asthma and future exacerbations: A prospective cohort study.
    Respir Med. 2022;200:106924.
    >> Share

  339. HUGHES R, Rapsomaniki E, Janson C, Keen C, et al
    Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study.
    Respir Med. 2022;200:106921.
    >> Share

  340. CAZZOLA M, Braido F, Calzetta L, Matera MG, et al
    The 5T approach in asthma: Triple Therapy Targeting Treatable Traits.
    Respir Med. 2022;200:106915.
    >> Share

  341. LUOTO J, Pihlsgard M, Pistolesi M, Paoletti M, et al
    Emphysema severity index (ESI) associated with respiratory death in a large Swedish general population.
    Respir Med. 2022;200:106899.
    >> Share

  342. LEONARD SI, Turi ER, Powell JS, Usseglio J, et al
    Associations of asthma self-management and mental health in adolescents: A scoping review.
    Respir Med. 2022;200:106897.
    >> Share

  343. SINGH D, Rabe KF, Martinez FJ, Krull M, et al
    Relationship between prior inhaled corticosteroid use and benefits ofbudesonide/glycopyrronium/formoterol fumarate dihydrate on exacerbations, symptoms, health-related quality of life, and lung function in patients with chronic obstructive pulmonary d
    Respir Med. 2022;197:106857.
    >> Share

  344. BRUSSE-KEIZER M, Citgez E, Zuur-Telgen M, Kerstjens HAM, et al
    Difference in survival between COPD patients with an impaired immune reaction versus an adequate immune reaction to seasonal influenza vaccination: The COMIC study.
    Respir Med. 2022;197:106851.
    >> Share

  345. SULKU J, Janson C, Melhus H, Stallberg B, et al
    Changes in critical inhaler technique errors in inhaled COPD treatment - A one-year follow-up study in Sweden.
    Respir Med. 2022;197:106849.
    >> Share

  346. COLAK Y, Nordestgaard BG, Vestbo J, Afzal S, et al
    Potential clinical implications of targeted spirometry for detection of COPD: A contemporary population-based cohort study.
    Respir Med. 2022;197:106852.
    >> Share

  347. DA LUZ GOULART C, Oliveira MR, Sendin FA, Mendes RG, et al
    Prognostic value of key variables from cardiopulmonary exercise testing in patients with COPD: 42-month follow-up.
    Respir Med. 2022;197:106856.
    >> Share

  348. MANNINO D, Bogart M, Wu B, Germain G, et al
    Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: A real-world study.
    Respir Med. 2022;197:106807.
    >> Share

  349. YOHANNES AM, Casaburi R, Dryden S, Hanania NA, et al
    The effectiveness of pulmonary rehabilitation on chronic obstructive pulmonary disease patients with concurrent presence of comorbid depression and anxiety.
    Respir Med. 2022;197:106850.
    >> Share

    May 2022
  350. SON JH, Park JS, Lee JU, Kim MK, et al
    A genome-wide association study on frequent exacerbation of asthma depending on smoking status.
    Respir Med. 2022 May 17:106877. doi: 10.1016/j.rmed.2022.106877.
    >> Share

  351. IKWU I, Nicolas LG, Mehari A, Gillum RF, et al
    Fractional exhaled nitric oxide and mortality in asthma and chronic obstructive pulmonary disease in a national cohort aged 40 years and older.
    Respir Med. 2022 May 16:106879. doi: 10.1016/j.rmed.2022.106879.
    >> Share

  352. JIAO T, Schnitzer ME, Forget A, Blais L, et al
    Identifying asthma patients at high risk of exacerbation in a routine visit: A machine learning model.
    Respir Med. 2022;198:106866.
    >> Share

  353. GOLAM SM, Janson C, Beasley R, FitzGerald JM, et al
    The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study.
    Respir Med. 2022;200:106863.
    >> Share

  354. SIRAJ RA, McKeever TM, Gibson JE, Bolton CE, et al
    Incidence of depression and antidepressant prescription in patients with COPD: A large UK population-based cohort study.
    Respir Med. 2022;196:106804.
    >> Share

  355. HARTMAN JE, Welling JBA, Klooster K, Carpaij OA, et al
    Survival in COPD patients treated with bronchoscopic lung volume reduction.
    Respir Med. 2022;196:106825.
    >> Share

  356. HESSE K, Bourke S, Steer J
    Heart failure in patients with COPD exacerbations: Looking below the tip of the iceberg.
    Respir Med. 2022;196:106800.
    >> Share

    April 2022
  357. CHIU YC, Chang WP, Tang GJ, Lan TY, et al
    Chronic obstructive pulmonary disease is associated with a higher risk of functional gastrointestinal disorders.
    Respir Med. 2022;197:106833.
    >> Share

  358. OBLING N, Backer V, Hurst JR, Bodtger U, et al
    Nasal and systemic inflammation in Chronic Obstructive Pulmonary Disease (COPD).
    Respir Med. 2022;195:106774.
    >> Share

  359. MACDONALD DM, Palzer EF, Abbasi A, Baldomero AK, et al
    Chronotropic index during 6-minute walk and acute respiratory events in COPDGene.
    Respir Med. 2022;194:106775.
    >> Share

    March 2022
  360. KORN S, Milger K, Skowasch D, Timmermann H, et al
    Corrigendum to "The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control" [Respir. Med. 195 (2022) 106793].
    Respir Med. 2022;196:106827.
    >> Share

  361. RILEY L, Lascano J
    Labelling Alpha-1 antitrypsin deficiency in the medical record - A call to action.
    Respir Med. 2022;193:106749.
    >> Share

  362. YOHANNES AM, Casaburi R, Dryden S, Hanania NA, et al
    Predictors of premature discontinuation and prevalence of dropouts from a pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease.
    Respir Med. 2022;193:106742.
    >> Share

  363. PHILLIPS TM, Moloney C, Sneath E, Beccaria G, et al
    Associated factors, assessment, management, and outcomes of patients who present to the emergency department for acute exacerbation of chronic obstructive pulmonary disease: A scoping review.
    Respir Med. 2022;193:106747.
    >> Share

    February 2022
  364. KORN S, Milger K, Skowasch D, Timmermann H, et al
    The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control.
    Respir Med. 2022;195:106793.
    >> Share

  365. BENDIEN SA, van Leeuwen MM, Lau HS, Ten Brinke A, et al
    Home-based intravenous treatment with reslizumab for severe asthma in the Netherlands - An evaluation.
    Respir Med. 2022 Feb 23:106776. doi: 10.1016/j.rmed.2022.106776.
    >> Share

  366. AL-AHMAD M, Webb D
    A prospective study of switching asthma patients from a Fixed-Dose Combination (FDC) Inhaled Corticosteroid [ICS]/Long-Acting Beta Agonist [LABA] therapy delivered by Dry Powder Inhaler (DPI) to ICS/LABA delivered by pressurised Metered Dose Inhaler (
    Respir Med. 2022;194:106771.
    >> Share

  367. ABOZID H, Baxter CA, Hartl S, Braun E, et al
    Distribution of chronic cough phenotypes in the general population: A cross-sectional analysis of the LEAD cohort in Austria.
    Respir Med. 2022;192:106726.
    >> Share

  368. MAROTT JL, Colak Y, Ingebrigtsen TS, Vestbo J, et al
    Exacerbation history, severity of dyspnoea and maintenance treatment predicts risk of future exacerbations in patients with COPD in the general population.
    Respir Med. 2022;192:106725.
    >> Share

    January 2022
  369. JI Z, Lopez-de-Andres A, Jimenez-Garcia R, Maestre-Miquel C, et al
    Mental health in patients with asthma: A population-based case-control study.
    Respir Med. 2022;193:106758.
    >> Share

  370. VRSALOVIC R, Korosec P, Stefanovic IM, Bidovec-Stojkovic U, et al
    Value of thymic stromal lymphopoietin as a biomarker in children with asthma.
    Respir Med. 2022;193:106757.
    >> Share

  371. METERSKY ML, Choate R, Aksamit TR, Conrad D, et al
    Stenotrophomonas maltophilia in patients with bronchiectasis: An analysis of the US bronchiectasis and NTM Research Registry.
    Respir Med. 2022;193:106746.
    >> Share

  372. TAKASAKA N, Hosaka Y, Fukuda T, Shinfuku K, et al
    Impact of emphysema on the prognosis of Mycobacterium avium complex pulmonary disease.
    Respir Med. 2022;192:106738.
    >> Share

  373. ELBORN JS, Blasi F, Haworth CS, Ballmann M, et al
    Bronchiectasis and inhaled tobramycin: A literature review.
    Respir Med. 2022;192:106728.
    >> Share

  374. BOURDIN A, Molinari N
    Non-optimal methodology questions indirect treatment comparison of dupilumab vs. other biologics in severe asthma.
    Respir Med. 2022;191:105999.
    >> Share

  375. BATEMAN ED, Khan AH, Xu Y, Guyot P, et al
    Response to the correspondence: "Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma".
    Respir Med. 2022;191:106088.
    >> Share

  376. MARTIN N, Papi A, Bratton DJ, Chan R, et al
    Comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma [Respir Med 2020].
    Respir Med. 2022;191:106065.
    >> Share

  377. BATEMAN ED, Khan AH, Xu Y, Guyot P, et al
    Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma.
    Respir Med. 2022;191:105991.
    >> Share

  378. SHEIKH D, Tripathi N, Chandler TR, Furmanek S, et al
    Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non- SARS-CoV-2 community-acquired pneumonia.
    Respir Med. 2022;191:106714.
    >> Share

  379. BERGHAUS TM, Karschnia P, Haberl S, Schwaiblmair M, et al
    Disproportionate decline in admissions for exacerbated COPD during the COVID-19 pandemic.
    Respir Med. 2022;191:106120.
    >> Share

  380. MIR T, Uddin M, Khalil A, Lohia P, et al
    Mortality outcomes associated with invasive aspergillosis among acute exacerbation of chronic obstructive pulmonary disease patient population.
    Respir Med. 2022;191:106720.
    >> Share

  381. OBLING N, Rangelov B, Backer V, Hurst JR, et al
    Upper airway symptoms and Small Airways Disease in Chronic Obstructive Pulmonary Disease, COPD.
    Respir Med. 2022;191:106710.
    >> Share

  382. JALASTO J, Lassmann-Klee P, Schyllert C, Luukkonen R, et al
    Occupation, socioeconomic status and chronic obstructive respiratory diseases - The EpiLung study in Finland, Estonia and Sweden.
    Respir Med. 2022;191:106403.
    >> Share

  383. OBI ON, Judson MA, Birring SS, Maier LA, et al
    Assessment of dyspnea in sarcoidosis using the Baseline Dyspnea Index (BDI) and the Transition Dyspnea Index (TDI).
    Respir Med. 2022;191:106436.
    >> Share

  384. BATEMAN ED, Khan AH, Xu Y, Guyot P, et al
    Response to comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020).
    Respir Med. 2022;191:106106.
    >> Share

    December 2021
  385. TERPSTRA LC, Altenburg J, Mohamed Hoesein FA, Bronsveld I, et al
    The effect of maintenance azithromycin on radiological features in patients with bronchiectasis - Analysis from the BAT randomized controlled trial.
    Respir Med. 2021;192:106718.
    >> Share

  386. MONTEIRO C, Maricoto T, Prazeres F, Augusto Simoes P, et al
    Determining factors associated with inhaled therapy adherence on asthma and COPD: A systematic review and meta-analysis of the global literature.
    Respir Med. 2021;191:106724.
    >> Share

  387. WILGUS ML, Abtin F, Markovic D, Tashkin DP, et al
    Panlobular emphysema is associated with COPD disease severity: A study of emphysema subtype by computed tomography.
    Respir Med. 2021;192:106717.
    >> Share

  388. BARTOLI ML, Latorre M, Vagaggini B, Nieri D, et al
    Are sputum eosinophils associated with a different phenotype in COPD patients? A retrospective study.
    Respir Med. 2021;190:106672.
    >> Share

  389. PENG J, Wu F, Tian H, Yang H, et al
    Clinical characteristics of and risk factors for small airway dysfunction detected by impulse oscillometry.
    Respir Med. 2021;190:106681.
    >> Share

  390. MONGIARDO MA, Robinson SA, Finer EB, Cruz Rivera PN, et al
    The Effect of a web-based physical activity intervention on COPD knowledge: A secondary cohort study.
    Respir Med. 2021;190:106677.
    >> Share

  391. LEE CT, Chien JY, Hsu MJ, Wu HD, et al
    Inspiratory muscle activation during inspiratory muscle training in patients with COPD.
    Respir Med. 2021;190:106676.
    >> Share

  392. YAMAMOTO A, Nakamoto H, Yamaguchi T, Sakai H, et al
    Validity of a novel respiratory rate monitor comprising stretchable strain sensors during a 6-min walking test in patients with chronic pulmonary obstructive disease.
    Respir Med. 2021;190:106675.
    >> Share

  393. CAILLE P, Alexandre F, Molinier V, Heraud N, et al
    The role of personality traits in inpatient pulmonary rehabilitation response in patients with chronic obstructive pulmonary disease.
    Respir Med. 2021;190:106680.
    >> Share

  394. AL CHIKHANIE Y, Bailly S, Amroussia I, Veale D, et al
    Trajectories of COPD patients' response to repeated pulmonary rehabilitation programs.
    Respir Med. 2021;190:106678.
    >> Share

  395. IRINA BP, Steluta MM, Emanuela T, Diana M, et al
    Respiratory muscle training program supplemented by a cell-phone application in COPD patients with severe airflow limitation.
    Respir Med. 2021;190:106679.
    >> Share

    November 2021
  396. FAN Q, Ong ASE, Koh MS, Doshi K, et al
    The mediating role of trust in physician and self-efficacy in understanding medication adherence in severe asthma.
    Respir Med. 2021;190:106673.
    >> Share

  397. JEONG JS, Kim JS, You YS, Yeom SW, et al
    COPD is a risk factor for COVID-19, but does not confer increased severity of the disease.
    Respir Med. 2021;189:106640.
    >> Share

  398. SUISSA S, Dell'Aniello S, Ernst P
    Comparing initial LABA-ICS inhalers in COPD: Real-world effectiveness and safety.
    Respir Med. 2021;189:106645.
    >> Share

  399. PALM A, Ekstrom M
    Hypoxemia severity and survival in ILD and COPD on long-term oxygen therapy - The population-based DISCOVERY study.
    Respir Med. 2021;189:106659.
    >> Share

  400. DE BISSCHOP C, Caron F, Ingrand P, Bretonneau Q, et al
    Does branched-chain amino acid supplementation improve pulmonary rehabilitation effect in COPD?
    Respir Med. 2021;189:106642.
    >> Share

  401. KARIM A, Muhammad T, Ustrana S, Qaisar R, et al
    Intestinal permeability marker zonulin as a predictor of sarcopenia in chronic obstructive pulmonary disease.
    Respir Med. 2021;189:106662.
    >> Share

  402. OIE MR, Sue-Chu M, Helvik AS, Steinsvag SK, et al
    Rhinosinusitis without nasal polyps is associated with poorer health-related quality of life in COPD.
    Respir Med. 2021;189:106661.
    >> Share

  403. KUNUTSOR SK, Jae SY, Makikallio TH, Kurl S, et al
    High fitness levels offset the increased risk of chronic obstructive pulmonary disease due to low socioeconomic status: A cohort study.
    Respir Med. 2021;189:106647.
    >> Share

  404. AL-MOAMARY MS, Kokturk N, Idrees MM, Sen E, et al
    Unmet need in the management of chronic obstructive pulmonary disease in the Middle East and Africa region: An expert panel consensus.
    Respir Med. 2021;189:106641.
    >> Share

  405. IWAKURA M, Wakasa M, Okura K, Kawagoshi A, et al
    Functionally relevant threshold of inspiratory muscle strength in patients with chronic obstructive pulmonary disease.
    Respir Med. 2021;188:106625.
    >> Share

  406. AGGARWAL R, Lam AC, Huang J, Hueniken K, et al
    Stratification and management of patients ineligible for lung cancer screening.
    Respir Med. 2021;188:106610.
    >> Share

  407. ZAIGHAM S, Zhou X, Molin M, Sjolander A, et al
    Importance of type and degree of IgE sensitisation for defining fractional exhaled nitric oxide reference values.
    Respir Med. 2021;188:106621.
    >> Share

  408. HARTMAN JE, Conway F, Degano B, Augustijn SWS, et al
    Rate of lung function decline slows in the 3 years after targeted lung denervation in COPD.
    Respir Med. 2021;188:106604.
    >> Share

  409. KEMP R, Pustulka I, Boerner G, Smela B, et al
    Relationship between FEV1 decline and mortality in patients with bronchiolitis obliterans syndrome-a systematic literature review.
    Respir Med. 2021;188:106608.
    >> Share

    October 2021
  410. CZIRA A, Turner M, Martin A, Hinds D, et al
    A systematic literature review of burden of illness in adults with uncontrolled moderate/severe asthma.
    Respir Med. 2021;191:106670.
    >> Share

  411. ROGLIANI P, Ritondo BL, Puxeddu E, Cazzola M, et al
    Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review.
    Respir Med. 2021;189:106639.
    >> Share

  412. CHEN J, Weldemichael L, Zeng S, Giang B, et al
    Actigraphy informs distinct patient-centered outcomes in Pre-COPD.
    Respir Med. 2021;187:106543.
    >> Share

  413. RODRIGUEZ-GARCIA C, Blanco-Aparicio M, Nieto-Fontarigo JJ, Blanco-Cid N, et al
    Efficacy of mepolizumab in usual clinical practice and characteristics of responders.
    Respir Med. 2021;187:106595.
    >> Share

  414. AGUSTI A, Barnes N, Cruz AA, Gibson PG, et al
    Moving towards a Treatable Traits model of care for the management of obstructive airways diseases.
    Respir Med. 2021;187:106572.
    >> Share

  415. HOSKING L, Yeo A, Hoffman J, Chiano M, et al
    Genetics plays a limited role in predicting chronic obstructive pulmonary disease treatment response and exacerbation.
    Respir Med. 2021;187:106573.
    >> Share

  416. WAN ES, Goldstein RL, Garshick E, DeMeo DL, et al
    Molecular markers of aging, exercise capacity, & physical activity in COPD.
    Respir Med. 2021;187:106576.
    >> Share

  417. RIIKONEN R, Korppi M, Tormanen S, Koponen P, et al
    Risk factors for irreversible airway obstruction after infant bronchiolitis.
    Respir Med. 2021;187:106545.
    >> Share

    September 2021
  418. KAPUR N, Stroil-Salama E, Morgan L, Yerkovich S, et al
    Factors associated with "Frequent Exacerbator" phenotype in children with bronchiectasis: The first report on children from the Australian Bronchiectasis Registry.
    Respir Med. 2021;188:106627.
    >> Share

  419. OLIVEIRA A, Quach S, Alsubheen S, Dasouki S, et al
    Rapid access rehabilitation after exacerbations of COPD - A qualitative study.
    Respir Med. 2021;186:106532.
    >> Share

  420. LEO F, Bannehr M, Valenta S, Lippeck M, et al
    Impact of a computerized physician order entry (CPOE)-based antibiotic stewardship intervention on the treatment duration for pneumonia and COPD exacerbations.
    Respir Med. 2021;186:106546.
    >> Share

  421. GAZOURIAN L, Regis SM, Pagura EJ, Price LL, et al
    Qualitative coronary artery calcification scores and risk of all cause, COPD and pneumonia hospital admission in a large CT lung cancer screening cohort.
    Respir Med. 2021;186:106540.
    >> Share

  422. NIKOLAOU V, Massaro S, Garn W, Fakhimi M, et al
    The cardiovascular phenotype of Chronic Obstructive Pulmonary Disease (COPD): Applying machine learning to the prediction of cardiovascular comorbidities.
    Respir Med. 2021;186:106528.
    >> Share

  423. CAMAC ER, Voelker H, Criner GJ
    Impact of COPD exacerbations leading to hospitalization on general and disease-specific quality of life.
    Respir Med. 2021;186:106526.
    >> Share

  424. LINDBERG A, Lindberg L, Sawalha S, Nilsson U, et al
    Large underreporting of COPD as cause of death-results from a population-based cohort study.
    Respir Med. 2021;186:106518.
    >> Share

    August 2021
  425. VITACCA M, Ambrosino N, Belli S, Vigna M, et al
    The severity of acute exacerbations of COPD and the effectiveness of pulmonary rehabilitation.
    Respir Med. 2021;184:106465.
    >> Share

  426. GILLIAM EA, Kilgore KL, Liu Y, Bernier L, et al
    Managing the experience of breathlessness with Tai Chi: A qualitative analysis from a randomized controlled trial in COPD.
    Respir Med. 2021;184:106463.
    >> Share

  427. GUO C, Yu T, Chang LY, Bo Y, et al
    Mortality risk attributable to classification of chronic obstructive pulmonary disease and reduced lung function: A 21-year longitudinal cohort study.
    Respir Med. 2021;184:106471.
    >> Share

  428. METERAN H, Thomsen SF, Miller MR, Hjelmborg J, et al
    Impact of the spirometric definition on comorbidities in chronic obstructive pulmonary disease.
    Respir Med. 2021;184:106399.
    >> Share

  429. TAKEI N, Suzuki M, Tanabe N, Oguma A, et al
    Combined assessment of pulmonary arterial enlargement and coronary calcification predicts the prognosis of patients with chronic obstructive pulmonary disease.
    Respir Med. 2021;185:106520.
    >> Share

  430. CASTELLO-SIMOES V, Kabbach EZ, Schafauser NS, Camargo PF, et al
    Brain-heart autonomic axis across different clinical status and severity of chronic obstructive pulmonary disease.
    Respir Med. 2021;185:106511.
    >> Share

  431. CORLATEANU A, Plahotniuc A, Corlateanu O, Botnaru V, et al
    Multidimensional indices in the assessment of chronic obstructive pulmonary disease.
    Respir Med. 2021;185:106519.
    >> Share

  432. MARTINEZ FJ, Rabe KF, Ferguson GT, Wedzicha JA, et al
    Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial.
    Respir Med. 2021;185:106509.
    >> Share

  433. KELLERER C, Kahnert K, Trudzinski FC, Lutter J, et al
    COPD maintenance medication is linked to left atrial size: Results from the COSYCONET cohort.
    Respir Med. 2021;185:106461.
    >> Share

  434. PATHAK JL, Yan Y, Zhang Q, Wang L, et al
    The role of oral microbiome in respiratory health and diseases.
    Respir Med. 2021;185:106475.
    >> Share

  435. ANDRIANOPOULOS V, Gloeckl R, Schneeberger T, Jarosch I, et al
    Benefits of pulmonary rehabilitation in COPD patients with mild cognitive impairment - A pilot study.
    Respir Med. 2021;185:106478.
    >> Share

    June 2021
  436. SHE W, Jia S, Hua Y, Feng X, et al
    The effect of nitrogen dioxide and atmospheric pressure on hospitalization risk for chronic obstructive pulmonary disease in Guangzhou, China.
    Respir Med. 2021;182:106424.
    >> Share

  437. CANTOR JO, Ma S, Liu X, Campos MA, et al
    A 28-day clinical trial of aerosolized hyaluronan in alpha-1 antiprotease deficiency COPD using desmosine as a surrogate marker for drug efficacy.
    Respir Med. 2021;182:106402.
    >> Share

  438. MARTH K, Renner A, Pohl W
    TRICOP - A Real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD.
    Respir Med. 2021;182:106398.
    >> Share

  439. KRAEN M, Frantz S, Nihlen U, Engstrom G, et al
    Fibroblast growth factor 23 is an independent marker of COPD and is associated with impairment of pulmonary function and diffusing capacity.
    Respir Med. 2021;182:106404.
    >> Share

  440. KIM C, Ko Y, Lee JS, Rhee CK, et al
    Predicting long-term mortality with two different criteria of exercise-induced desaturation in COPD.
    Respir Med. 2021;182:106393.
    >> Share

  441. AMADO CA, Munoz P, Garcia-Unzueta M, Aguero J, et al
    High parathyroid hormone predicts exacerbations in COPD patients with hypovitaminosis D.
    Respir Med. 2021;182:106416.
    >> Share

  442. AL-QEREM WA, Jarab AS
    Applicability of GLI 2012 spirometry equation among preschool aged Jordanian.
    Respir Med. 2021;182:106397.
    >> Share

    May 2021
  443. PUDDU PE, Menotti A, Kromhout D, Kafatos A, et al
    Chronic bronchitis in the 50-year follow-up of the European cohorts of the Seven Countries Study: prevalence, mortality and association with cardiovascular diseases.
    Respir Med. 2021;181:106385.
    >> Share

  444. VINCKEN S, Sylvia V, Daniel S, Thomas E, et al
    The role of FeNO in stable COPD patients with eosinophilic airway inflammation.
    Respir Med. 2021;181:106377.
    >> Share

  445. CORDOVA-RIVERA L, Gardiner PA, Gibson PG, Winkler EAH, et al
    Sedentary time in people with obstructive airway diseases.
    Respir Med. 2021;181:106367.
    >> Share

  446. HEUBEL AD, Kabbach EZ, Schafauser NS, Phillips SA, et al
    Noninvasive ventilation acutely improves endothelial function in exacerbated COPD patients.
    Respir Med. 2021;181:106389.
    >> Share

    April 2021
  447. PINI L, Giordani J, Gardini G, Concoreggi C, et al
    Emergency department admission and hospitalization for COPD exacerbation and particulate matter short-term exposure in Brescia, a highly polluted town in northern Italy.
    Respir Med. 2021;179:106334.
    >> Share

  448. YANGUI F, Touil A, Antit S, Zakhama L, et al
    COPD prevalence in smokers with stable ischemic heart disease: A cross-sectional study in Tunisia.
    Respir Med. 2021;179:106335.
    >> Share

  449. VERBERKT CA, van den Beuken-van Everdingen MHJ, Dirksen CD, Schols JMGA, et al
    Cost-effectiveness of sustained-release morphine for refractory breathlessness in COPD: A randomized clinical trial.
    Respir Med. 2021;179:106330.
    >> Share

  450. TIOTIU A, Ioan I, Poussel M, Schweitzer C, et al
    Comparative analysis between available challenge tests in the hyperventilation syndrome.
    Respir Med. 2021;179:106329.
    >> Share

  451. ARMSTRONG M, Hume E, McNeillie L, Chambers F, et al
    Behavioural modification interventions alongside pulmonary rehabilitation improve COPD patients' experiences of physical activity.
    Respir Med. 2021;180:106353.
    >> Share

  452. LAMMI MR, Ghonim MA, Johnson J, D'Aquin J, et al
    Acute effect of inhaled iloprost on exercise dynamic hyperinflation in COPD patients: A randomized crossover study.
    Respir Med. 2021;180:106354.
    >> Share

    March 2021
  453. TURAN PA, Turan O, Guldaval F, Anar C, et al
    Transitions between COPD groups: A cross-sectional study in Turkey.
    Respir Med. 2021;178:106310.
    >> Share

    January 2021
  454. ZELL-BARAN LM, Krefft SD, Moore CM, Wolff J, et al
    Multiple breath washout: A noninvasive tool for identifying lung disease in symptomatic military deployers.
    Respir Med. 2021;176:106281.
    >> Share

  455. OLIVEIRA CC, Annoni R, Lee AL, McGinley J, et al
    Falls prevalence and risk factors in people with chronic obstructive pulmonary disease: A systematic review.
    Respir Med. 2021;176:106284.
    >> Share

  456. LOPEZ-PINTOR E, Grau J, Gonzalez I, Bernal-Soriano MC, et al
    Impact of patients' perception of COPD and treatment on adherence and health-related quality of life in real-world: Study in 53 community pharmacies.
    Respir Med. 2021;176:106280.
    >> Share

  457. BAHA A, Kokturk N
    Physician's attitude against COPD guidelines and the choice of first-line treatment for COPD.
    Respir Med. 2021;176:106273.
    >> Share

  458. BJERRUM AS, Skjold T, Schmid JM
    Oral corticosteroid sparing effects of anti-IL5/ anti-IL5 receptor treatment after 2 years of treatment.
    Respir Med. 2021;176:106260.
    >> Share

  459. FRANCE G, Orme MW, Greening NJ, Steiner MC, et al
    Cognitive function following pulmonary rehabilitation and post-discharge recovery from exacerbation in people with COPD.
    Respir Med. 2021;176:106249.
    >> Share

  460. KEOGH E, Mark Williams E
    Managing malnutrition in COPD: A review.
    Respir Med. 2021;176:106248.
    >> Share

  461. ZAIGHAM S, Dencker M, Karlsson MK, Thorsson O, et al
    Lung function is associated with tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in school-aged children.
    Respir Med. 2021;176:106235.
    >> Share

  462. KOHLBRENNER D, Clarenbach CF, Thiel S, Roeder M, et al
    A few more steps lead to improvements in endothelial function in severe and very severe COPD.
    Respir Med. 2021;176:106246.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016